<html>
    <head>
        <meta charset="utf-8">
        
            <script>function neighbourhoodHighlight(params) {
  // console.log("in nieghbourhoodhighlight");
  allNodes = nodes.get({ returnType: "Object" });
  // originalNodes = JSON.parse(JSON.stringify(allNodes));
  // if something is selected:
  if (params.nodes.length > 0) {
    highlightActive = true;
    var i, j;
    var selectedNode = params.nodes[0];
    var degrees = 2;

    // mark all nodes as hard to read.
    for (let nodeId in allNodes) {
      // nodeColors[nodeId] = allNodes[nodeId].color;
      allNodes[nodeId].color = "rgba(200,200,200,0.5)";
      if (allNodes[nodeId].hiddenLabel === undefined) {
        allNodes[nodeId].hiddenLabel = allNodes[nodeId].label;
        allNodes[nodeId].label = undefined;
      }
    }
    var connectedNodes = network.getConnectedNodes(selectedNode);
    var allConnectedNodes = [];

    // get the second degree nodes
    for (i = 1; i < degrees; i++) {
      for (j = 0; j < connectedNodes.length; j++) {
        allConnectedNodes = allConnectedNodes.concat(
          network.getConnectedNodes(connectedNodes[j])
        );
      }
    }

    // all second degree nodes get a different color and their label back
    for (i = 0; i < allConnectedNodes.length; i++) {
      // allNodes[allConnectedNodes[i]].color = "pink";
      allNodes[allConnectedNodes[i]].color = "rgba(150,150,150,0.75)";
      if (allNodes[allConnectedNodes[i]].hiddenLabel !== undefined) {
        allNodes[allConnectedNodes[i]].label =
          allNodes[allConnectedNodes[i]].hiddenLabel;
        allNodes[allConnectedNodes[i]].hiddenLabel = undefined;
      }
    }

    // all first degree nodes get their own color and their label back
    for (i = 0; i < connectedNodes.length; i++) {
      // allNodes[connectedNodes[i]].color = undefined;
      allNodes[connectedNodes[i]].color = nodeColors[connectedNodes[i]];
      if (allNodes[connectedNodes[i]].hiddenLabel !== undefined) {
        allNodes[connectedNodes[i]].label =
          allNodes[connectedNodes[i]].hiddenLabel;
        allNodes[connectedNodes[i]].hiddenLabel = undefined;
      }
    }

    // the main node gets its own color and its label back.
    // allNodes[selectedNode].color = undefined;
    allNodes[selectedNode].color = nodeColors[selectedNode];
    if (allNodes[selectedNode].hiddenLabel !== undefined) {
      allNodes[selectedNode].label = allNodes[selectedNode].hiddenLabel;
      allNodes[selectedNode].hiddenLabel = undefined;
    }
  } else if (highlightActive === true) {
    // console.log("highlightActive was true");
    // reset all nodes
    for (let nodeId in allNodes) {
      // allNodes[nodeId].color = "purple";
      allNodes[nodeId].color = nodeColors[nodeId];
      // delete allNodes[nodeId].color;
      if (allNodes[nodeId].hiddenLabel !== undefined) {
        allNodes[nodeId].label = allNodes[nodeId].hiddenLabel;
        allNodes[nodeId].hiddenLabel = undefined;
      }
    }
    highlightActive = false;
  }

  // transform the object into an array
  var updateArray = [];
  if (params.nodes.length > 0) {
    for (let nodeId in allNodes) {
      if (allNodes.hasOwnProperty(nodeId)) {
        // console.log(allNodes[nodeId]);
        updateArray.push(allNodes[nodeId]);
      }
    }
    nodes.update(updateArray);
  } else {
    // console.log("Nothing was selected");
    for (let nodeId in allNodes) {
      if (allNodes.hasOwnProperty(nodeId)) {
        // console.log(allNodes[nodeId]);
        // allNodes[nodeId].color = {};
        updateArray.push(allNodes[nodeId]);
      }
    }
    nodes.update(updateArray);
  }
}

function filterHighlight(params) {
  allNodes = nodes.get({ returnType: "Object" });
  // if something is selected:
  if (params.nodes.length > 0) {
    filterActive = true;
    let selectedNodes = params.nodes;

    // hiding all nodes and saving the label
    for (let nodeId in allNodes) {
      allNodes[nodeId].hidden = true;
      if (allNodes[nodeId].savedLabel === undefined) {
        allNodes[nodeId].savedLabel = allNodes[nodeId].label;
        allNodes[nodeId].label = undefined;
      }
    }

    for (let i=0; i < selectedNodes.length; i++) {
      allNodes[selectedNodes[i]].hidden = false;
      if (allNodes[selectedNodes[i]].savedLabel !== undefined) {
        allNodes[selectedNodes[i]].label = allNodes[selectedNodes[i]].savedLabel;
        allNodes[selectedNodes[i]].savedLabel = undefined;
      }
    }

  } else if (filterActive === true) {
    // reset all nodes
    for (let nodeId in allNodes) {
      allNodes[nodeId].hidden = false;
      if (allNodes[nodeId].savedLabel !== undefined) {
        allNodes[nodeId].label = allNodes[nodeId].savedLabel;
        allNodes[nodeId].savedLabel = undefined;
      }
    }
    filterActive = false;
  }

  // transform the object into an array
  var updateArray = [];
  if (params.nodes.length > 0) {
    for (let nodeId in allNodes) {
      if (allNodes.hasOwnProperty(nodeId)) {
        updateArray.push(allNodes[nodeId]);
      }
    }
    nodes.update(updateArray);
  } else {
    for (let nodeId in allNodes) {
      if (allNodes.hasOwnProperty(nodeId)) {
        updateArray.push(allNodes[nodeId]);
      }
    }
    nodes.update(updateArray);
  }
}

function selectNode(nodes) {
  network.selectNodes(nodes);
  neighbourhoodHighlight({ nodes: nodes });
  return nodes;
}

function selectNodes(nodes) {
  network.selectNodes(nodes);
  filterHighlight({nodes: nodes});
  return nodes;
}

function highlightFilter(filter) {
  let selectedNodes = []
  let selectedProp = filter['property']
  if (filter['item'] === 'node') {
    let allNodes = nodes.get({ returnType: "Object" });
    for (let nodeId in allNodes) {
      if (allNodes[nodeId][selectedProp] && filter['value'].includes((allNodes[nodeId][selectedProp]).toString())) {
        selectedNodes.push(nodeId)
      }
    }
  }
  else if (filter['item'] === 'edge'){
    let allEdges = edges.get({returnType: 'object'});
    // check if the selected property exists for selected edge and select the nodes connected to the edge
    for (let edge in allEdges) {
      if (allEdges[edge][selectedProp] && filter['value'].includes((allEdges[edge][selectedProp]).toString())) {
        selectedNodes.push(allEdges[edge]['from'])
        selectedNodes.push(allEdges[edge]['to'])
      }
    }
  }
  selectNodes(selectedNodes)
}</script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
            
            
            
            
            

        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 600px;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             
             #loadingBar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width: 100%;
                 height: 600px;
                 background-color:rgba(200,200,200,0.8);
                 -webkit-transition: all 0.5s ease;
                 -moz-transition: all 0.5s ease;
                 -ms-transition: all 0.5s ease;
                 -o-transition: all 0.5s ease;
                 transition: all 0.5s ease;
                 opacity:1;
             }

             #bar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width:20px;
                 height:20px;
                 margin:auto auto auto auto;
                 border-radius:11px;
                 border:2px solid rgba(30,30,30,0.05);
                 background: rgb(0, 173, 246); /* Old browsers */
                 box-shadow: 2px 0px 4px rgba(0,0,0,0.4);
             }

             #border {
                 position:absolute;
                 top:10px;
                 left:10px;
                 width:500px;
                 height:23px;
                 margin:auto auto auto auto;
                 box-shadow: 0px 0px 4px rgba(0,0,0,0.2);
                 border-radius:10px;
             }

             #text {
                 position:absolute;
                 top:8px;
                 left:530px;
                 width:30px;
                 height:50px;
                 margin:auto auto auto auto;
                 font-size:22px;
                 color: #000000;
             }

             div.outerBorder {
                 position:relative;
                 top:400px;
                 width:600px;
                 height:44px;
                 margin:auto auto auto auto;
                 border:8px solid rgba(0,0,0,0.1);
                 background: rgb(252,252,252); /* Old browsers */
                 background: -moz-linear-gradient(top,  rgba(252,252,252,1) 0%, rgba(237,237,237,1) 100%); /* FF3.6+ */
                 background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,rgba(252,252,252,1)), color-stop(100%,rgba(237,237,237,1))); /* Chrome,Safari4+ */
                 background: -webkit-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Chrome10+,Safari5.1+ */
                 background: -o-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Opera 11.10+ */
                 background: -ms-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* IE10+ */
                 background: linear-gradient(to bottom,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* W3C */
                 filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#fcfcfc', endColorstr='#ededed',GradientType=0 ); /* IE6-9 */
                 border-radius:72px;
                 box-shadow: 0px 0px 10px rgba(0,0,0,0.2);
             }
             

             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
            
            <div id="mynetwork" class="card-body"></div>
        </div>

        
            <div id="loadingBar">
              <div class="outerBorder">
                <div id="text">0%</div>
                <div id="border">
                  <div id="bar"></div>
                </div>
              </div>
            </div>
        
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"group": 1, "id": "DB00864", "label": "Tacrolimus", "shape": "dot", "title": "DB00864"}, {"group": 1, "id": "DB00091", "label": "Cyclosporine", "shape": "dot", "title": "DB00091"}, {"group": 2, "id": "CAMLG", "label": "CAMLG", "shape": "dot", "title": "CAMLG"}, {"group": 2, "id": "CAML", "label": "CAML", "shape": "dot", "title": "CAML"}, {"group": 2, "id": "GET2", "label": "GET2", "shape": "dot", "title": "GET2"}, {"group": 2, "id": "PPP3R2", "label": "PPP3R2", "shape": "dot", "title": "PPP3R2"}, {"group": 2, "id": "CBLP", "label": "CBLP", "shape": "dot", "title": "CBLP"}, {"group": 2, "id": "PPP3RL", "label": "PPP3RL", "shape": "dot", "title": "PPP3RL"}, {"group": 2, "id": "PPIA", "label": "PPIA", "shape": "dot", "title": "PPIA"}, {"group": 2, "id": "CYPA", "label": "CYPA", "shape": "dot", "title": "CYPA"}, {"group": 2, "id": "PPIF", "label": "PPIF", "shape": "dot", "title": "PPIF"}, {"group": 2, "id": "CYP3", "label": "CYP3", "shape": "dot", "title": "CYP3"}, {"group": 2, "id": "FKBP1A", "label": "FKBP1A", "shape": "dot", "title": "FKBP1A"}, {"group": 2, "id": "FKBP1", "label": "FKBP1", "shape": "dot", "title": "FKBP1"}, {"group": 2, "id": "FKBP12", "label": "FKBP12", "shape": "dot", "title": "FKBP12"}, {"group": 3, "id": "Degenerative polyarthritis", "label": "Degenerative polyarthritis", "shape": "dot", "title": "Degenerative polyarthritis"}, {"group": 3, "id": "Asthenozoospermia", "label": "Asthenozoospermia", "shape": "dot", "title": "Asthenozoospermia"}, {"group": 3, "id": "Renal Cell Carcinoma", "label": "Renal Cell Carcinoma", "shape": "dot", "title": "Renal Cell Carcinoma"}, {"group": 3, "id": "Infection by Cryptococcus neoformans", "label": "Infection by Cryptococcus neoformans", "shape": "dot", "title": "Infection by Cryptococcus neoformans"}, {"group": 3, "id": "Scleroderma", "label": "Scleroderma", "shape": "dot", "title": "Scleroderma"}, {"group": 3, "id": "Esophageal Neoplasms", "label": "Esophageal Neoplasms", "shape": "dot", "title": "Esophageal Neoplasms"}, {"group": 3, "id": "Fibrodysplasia Ossificans Progressiva", "label": "Fibrodysplasia Ossificans Progressiva", "shape": "dot", "title": "Fibrodysplasia Ossificans Progressiva"}, {"group": 3, "id": "Graves Disease", "label": "Graves Disease", "shape": "dot", "title": "Graves Disease"}, {"group": 3, "id": "Heart failure", "label": "Heart failure", "shape": "dot", "title": "Heart failure"}, {"group": 3, "id": "Congestive heart failure", "label": "Congestive heart failure", "shape": "dot", "title": "Congestive heart failure"}, {"group": 3, "id": "Liver Cirrhosis, Experimental", "label": "Liver Cirrhosis, Experimental", "shape": "dot", "title": "Liver Cirrhosis, Experimental"}, {"group": 3, "id": "Lymphoma", "label": "Lymphoma", "shape": "dot", "title": "Lymphoma"}, {"group": 3, "id": "Neoplasms", "label": "Neoplasms", "shape": "dot", "title": "Neoplasms"}, {"group": 3, "id": "Parkinson Disease", "label": "Parkinson Disease", "shape": "dot", "title": "Parkinson Disease"}, {"group": 3, "id": "Plasmacytoma", "label": "Plasmacytoma", "shape": "dot", "title": "Plasmacytoma"}, {"group": 3, "id": "Systemic Scleroderma", "label": "Systemic Scleroderma", "shape": "dot", "title": "Systemic Scleroderma"}, {"group": 3, "id": "Dermatologic disorders", "label": "Dermatologic disorders", "shape": "dot", "title": "Dermatologic disorders"}, {"group": 3, "id": "Stomach Diseases", "label": "Stomach Diseases", "shape": "dot", "title": "Stomach Diseases"}, {"group": 3, "id": "Abscess", "label": "Abscess", "shape": "dot", "title": "Abscess"}, {"group": 3, "id": "Alzheimer\u0027s Disease", "label": "Alzheimer\u0027s Disease", "shape": "dot", "title": "Alzheimer\u0027s Disease"}, {"group": 3, "id": "Atrial Fibrillation", "label": "Atrial Fibrillation", "shape": "dot", "title": "Atrial Fibrillation"}, {"group": 3, "id": "Autoimmune Diseases", "label": "Autoimmune Diseases", "shape": "dot", "title": "Autoimmune Diseases"}, {"group": 3, "id": "Bipolar Disorder", "label": "Bipolar Disorder", "shape": "dot", "title": "Bipolar Disorder"}, {"group": 3, "id": "Malignant neoplasm of breast", "label": "Malignant neoplasm of breast", "shape": "dot", "title": "Malignant neoplasm of breast"}, {"group": 3, "id": "Malignant Neoplasms", "label": "Malignant Neoplasms", "shape": "dot", "title": "Malignant Neoplasms"}, {"group": 3, "id": "Motor Neuron Disease", "label": "Motor Neuron Disease", "shape": "dot", "title": "Motor Neuron Disease"}, {"group": 3, "id": "Arthritis aggravated", "label": "Arthritis aggravated", "shape": "dot", "title": "Arthritis aggravated"}, {"group": 3, "id": "Parkinsonian Disorders", "label": "Parkinsonian Disorders", "shape": "dot", "title": "Parkinsonian Disorders"}, {"group": 3, "id": "Systemic Inflammatory Response Syndrome", "label": "Systemic Inflammatory Response Syndrome", "shape": "dot", "title": "Systemic Inflammatory Response Syndrome"}, {"group": 3, "id": "Simple renal cyst", "label": "Simple renal cyst", "shape": "dot", "title": "Simple renal cyst"}, {"group": 3, "id": "Muscular Dystrophy, Oculopharyngeal", "label": "Muscular Dystrophy, Oculopharyngeal", "shape": "dot", "title": "Muscular Dystrophy, Oculopharyngeal"}, {"group": 3, "id": "Squamous cell carcinoma of esophagus", "label": "Squamous cell carcinoma of esophagus", "shape": "dot", "title": "Squamous cell carcinoma of esophagus"}, {"group": 3, "id": "Malignant neoplasm of prostate", "label": "Malignant neoplasm of prostate", "shape": "dot", "title": "Malignant neoplasm of prostate"}, {"group": 3, "id": "Alzheimer Disease, Late Onset", "label": "Alzheimer Disease, Late Onset", "shape": "dot", "title": "Alzheimer Disease, Late Onset"}, {"group": 3, "id": "3-Methylglutaconic aciduria type 2", "label": "3-Methylglutaconic aciduria type 2", "shape": "dot", "title": "3-Methylglutaconic aciduria type 2"}, {"group": 3, "id": "Prostate carcinoma", "label": "Prostate carcinoma", "shape": "dot", "title": "Prostate carcinoma"}, {"group": 3, "id": "Breast Carcinoma", "label": "Breast Carcinoma", "shape": "dot", "title": "Breast Carcinoma"}, {"group": 3, "id": "Central Core Myopathy (disorder)", "label": "Central Core Myopathy (disorder)", "shape": "dot", "title": "Central Core Myopathy (disorder)"}, {"group": 3, "id": "Lewy Body Disease", "label": "Lewy Body Disease", "shape": "dot", "title": "Lewy Body Disease"}, {"group": 3, "id": "Invasive carcinoma of breast", "label": "Invasive carcinoma of breast", "shape": "dot", "title": "Invasive carcinoma of breast"}, {"group": 3, "id": "Primary malignant neoplasm", "label": "Primary malignant neoplasm", "shape": "dot", "title": "Primary malignant neoplasm"}, {"group": 3, "id": "Adult Lymphoma", "label": "Adult Lymphoma", "shape": "dot", "title": "Adult Lymphoma"}, {"group": 3, "id": "Childhood Lymphoma", "label": "Childhood Lymphoma", "shape": "dot", "title": "Childhood Lymphoma"}, {"group": 3, "id": "Renal carcinoma", "label": "Renal carcinoma", "shape": "dot", "title": "Renal carcinoma"}, {"group": 3, "id": "Mammary Neoplasms", "label": "Mammary Neoplasms", "shape": "dot", "title": "Mammary Neoplasms"}, {"group": 3, "id": "AMYOTROPHIC LATERAL SCLEROSIS 1", "label": "AMYOTROPHIC LATERAL SCLEROSIS 1", "shape": "dot", "title": "AMYOTROPHIC LATERAL SCLEROSIS 1"}, {"group": 3, "id": "Renal cyst", "label": "Renal cyst", "shape": "dot", "title": "Renal cyst"}, {"group": 3, "id": "Episodic Kinesigenic Dyskinesia 1", "label": "Episodic Kinesigenic Dyskinesia 1", "shape": "dot", "title": "Episodic Kinesigenic Dyskinesia 1"}, {"group": 3, "id": "Malignant tumor of colon", "label": "Malignant tumor of colon", "shape": "dot", "title": "Malignant tumor of colon"}, {"group": 3, "id": "Cardiovascular Diseases", "label": "Cardiovascular Diseases", "shape": "dot", "title": "Cardiovascular Diseases"}, {"group": 3, "id": "Coronary Arteriosclerosis", "label": "Coronary Arteriosclerosis", "shape": "dot", "title": "Coronary Arteriosclerosis"}, {"group": 3, "id": "Diabetes", "label": "Diabetes", "shape": "dot", "title": "Diabetes"}, {"group": 3, "id": "Diabetes Mellitus", "label": "Diabetes Mellitus", "shape": "dot", "title": "Diabetes Mellitus"}, {"group": 3, "id": "Muscular Dystrophy, Duchenne", "label": "Muscular Dystrophy, Duchenne", "shape": "dot", "title": "Muscular Dystrophy, Duchenne"}, {"group": 3, "id": "Encephalomyelitis", "label": "Encephalomyelitis", "shape": "dot", "title": "Encephalomyelitis"}, {"group": 3, "id": "Fatty Liver", "label": "Fatty Liver", "shape": "dot", "title": "Fatty Liver"}, {"group": 3, "id": "Glioblastoma", "label": "Glioblastoma", "shape": "dot", "title": "Glioblastoma"}, {"group": 3, "id": "Glioma", "label": "Glioma", "shape": "dot", "title": "Glioma"}, {"group": 3, "id": "Hyperglycemia", "label": "Hyperglycemia", "shape": "dot", "title": "Hyperglycemia"}, {"group": 3, "id": "Intestinal Diseases", "label": "Intestinal Diseases", "shape": "dot", "title": "Intestinal Diseases"}, {"group": 3, "id": "Kidney Failure, Acute", "label": "Kidney Failure, Acute", "shape": "dot", "title": "Kidney Failure, Acute"}, {"group": 3, "id": "Acute lymphocytic leukemia", "label": "Acute lymphocytic leukemia", "shape": "dot", "title": "Acute lymphocytic leukemia"}, {"group": 3, "id": "Meningioma", "label": "Meningioma", "shape": "dot", "title": "Meningioma"}, {"group": 3, "id": "Myopathy", "label": "Myopathy", "shape": "dot", "title": "Myopathy"}, {"group": 3, "id": "Muscular Dystrophy", "label": "Muscular Dystrophy", "shape": "dot", "title": "Muscular Dystrophy"}, {"group": 3, "id": "Myocardial Infarction", "label": "Myocardial Infarction", "shape": "dot", "title": "Myocardial Infarction"}, {"group": 3, "id": "Nephrotic Syndrome", "label": "Nephrotic Syndrome", "shape": "dot", "title": "Nephrotic Syndrome"}, {"group": 3, "id": "Obesity", "label": "Obesity", "shape": "dot", "title": "Obesity"}, {"group": 3, "id": "Pancreatitis", "label": "Pancreatitis", "shape": "dot", "title": "Pancreatitis"}, {"group": 3, "id": "Tuberculosis", "label": "Tuberculosis", "shape": "dot", "title": "Tuberculosis"}, {"group": 3, "id": "Ulcer", "label": "Ulcer", "shape": "dot", "title": "Ulcer"}, {"group": 3, "id": "Ureteral obstruction", "label": "Ureteral obstruction", "shape": "dot", "title": "Ureteral obstruction"}, {"group": 3, "id": "Acute pancreatitis", "label": "Acute pancreatitis", "shape": "dot", "title": "Acute pancreatitis"}, {"group": 3, "id": "Amyloidosis", "label": "Amyloidosis", "shape": "dot", "title": "Amyloidosis"}, {"group": 3, "id": "Amyotrophic Lateral Sclerosis", "label": "Amyotrophic Lateral Sclerosis", "shape": "dot", "title": "Amyotrophic Lateral Sclerosis"}, {"group": 3, "id": "Renal fibrosis", "label": "Renal fibrosis", "shape": "dot", "title": "Renal fibrosis"}, {"group": 3, "id": "Myocardial Ischemia", "label": "Myocardial Ischemia", "shape": "dot", "title": "Myocardial Ischemia"}, {"group": 3, "id": "Adrenoleukodystrophy", "label": "Adrenoleukodystrophy", "shape": "dot", "title": "Adrenoleukodystrophy"}, {"group": 3, "id": "Mitochondrial Myopathies", "label": "Mitochondrial Myopathies", "shape": "dot", "title": "Mitochondrial Myopathies"}, {"group": 3, "id": "Tumor Progression", "label": "Tumor Progression", "shape": "dot", "title": "Tumor Progression"}, {"group": 3, "id": "Muscle degeneration", "label": "Muscle degeneration", "shape": "dot", "title": "Muscle degeneration"}, {"group": 3, "id": "Pancreatic carcinoma", "label": "Pancreatic carcinoma", "shape": "dot", "title": "Pancreatic carcinoma"}, {"group": 3, "id": "Malignant neoplasm of lung", "label": "Malignant neoplasm of lung", "shape": "dot", "title": "Malignant neoplasm of lung"}, {"group": 3, "id": "Adult Meningioma", "label": "Adult Meningioma", "shape": "dot", "title": "Adult Meningioma"}, {"group": 3, "id": "Adult Glioblastoma", "label": "Adult Glioblastoma", "shape": "dot", "title": "Adult Glioblastoma"}, {"group": 3, "id": "Childhood Glioblastoma", "label": "Childhood Glioblastoma", "shape": "dot", "title": "Childhood Glioblastoma"}, {"group": 3, "id": "Impaired cognition", "label": "Impaired cognition", "shape": "dot", "title": "Impaired cognition"}, {"group": 3, "id": "Glaucoma, Primary Open Angle", "label": "Glaucoma, Primary Open Angle", "shape": "dot", "title": "Glaucoma, Primary Open Angle"}, {"group": 3, "id": "Familial dilated cardiomyopathy", "label": "Familial dilated cardiomyopathy", "shape": "dot", "title": "Familial dilated cardiomyopathy"}, {"group": 3, "id": "Malignant neoplasm of pancreas", "label": "Malignant neoplasm of pancreas", "shape": "dot", "title": "Malignant neoplasm of pancreas"}, {"group": 3, "id": "Sepsis-Associated Encephalopathy", "label": "Sepsis-Associated Encephalopathy", "shape": "dot", "title": "Sepsis-Associated Encephalopathy"}, {"group": 3, "id": "Non-alcoholic Fatty Liver Disease", "label": "Non-alcoholic Fatty Liver Disease", "shape": "dot", "title": "Non-alcoholic Fatty Liver Disease"}, {"group": 3, "id": "Sleep Apnea, Central", "label": "Sleep Apnea, Central", "shape": "dot", "title": "Sleep Apnea, Central"}, {"group": 3, "id": "Metabolic Syndrome X", "label": "Metabolic Syndrome X", "shape": "dot", "title": "Metabolic Syndrome X"}, {"group": 3, "id": "Neurodegenerative Disorders", "label": "Neurodegenerative Disorders", "shape": "dot", "title": "Neurodegenerative Disorders"}, {"group": 3, "id": "Carcinogenesis", "label": "Carcinogenesis", "shape": "dot", "title": "Carcinogenesis"}, {"group": 3, "id": "Carcinoma of lung", "label": "Carcinoma of lung", "shape": "dot", "title": "Carcinoma of lung"}, {"group": 3, "id": "Colon Carcinoma", "label": "Colon Carcinoma", "shape": "dot", "title": "Colon Carcinoma"}, {"group": 3, "id": "Cockayne Syndrome, Type I", "label": "Cockayne Syndrome, Type I", "shape": "dot", "title": "Cockayne Syndrome, Type I"}, {"group": 3, "id": "Cardiomyopathies", "label": "Cardiomyopathies", "shape": "dot", "title": "Cardiomyopathies"}, {"group": 3, "id": "Ischemic stroke", "label": "Ischemic stroke", "shape": "dot", "title": "Ischemic stroke"}, {"group": 3, "id": "Glioblastoma Multiforme", "label": "Glioblastoma Multiforme", "shape": "dot", "title": "Glioblastoma Multiforme"}, {"group": 3, "id": "Meningioma, benign, no ICD-O subtype", "label": "Meningioma, benign, no ICD-O subtype", "shape": "dot", "title": "Meningioma, benign, no ICD-O subtype"}, {"group": 3, "id": "Liver carcinoma", "label": "Liver carcinoma", "shape": "dot", "title": "Liver carcinoma"}, {"group": 3, "id": "Steatohepatitis", "label": "Steatohepatitis", "shape": "dot", "title": "Steatohepatitis"}, {"group": 3, "id": "Memory dysfunction", "label": "Memory dysfunction", "shape": "dot", "title": "Memory dysfunction"}, {"group": 3, "id": "Common Variable Immunodeficiency", "label": "Common Variable Immunodeficiency", "shape": "dot", "title": "Common Variable Immunodeficiency"}, {"group": 3, "id": "Fever", "label": "Fever", "shape": "dot", "title": "Fever"}, {"group": 3, "id": "leukemia", "label": "leukemia", "shape": "dot", "title": "leukemia"}, {"group": 3, "id": "Leukemia, Myelocytic, Acute", "label": "Leukemia, Myelocytic, Acute", "shape": "dot", "title": "Leukemia, Myelocytic, Acute"}, {"group": 3, "id": "melanoma", "label": "melanoma", "shape": "dot", "title": "melanoma"}, {"group": 3, "id": "Neoplasm Metastasis", "label": "Neoplasm Metastasis", "shape": "dot", "title": "Neoplasm Metastasis"}, {"group": 3, "id": "Childhood Leukemia", "label": "Childhood Leukemia", "shape": "dot", "title": "Childhood Leukemia"}, {"group": 3, "id": "Acquired Hypogammaglobulinemia", "label": "Acquired Hypogammaglobulinemia", "shape": "dot", "title": "Acquired Hypogammaglobulinemia"}, {"group": 3, "id": "Carcinoma", "label": "Carcinoma", "shape": "dot", "title": "Carcinoma"}, {"group": 3, "id": "Malignant neoplasm of endometrium", "label": "Malignant neoplasm of endometrium", "shape": "dot", "title": "Malignant neoplasm of endometrium"}, {"group": 3, "id": "Malignant neoplasm of skin", "label": "Malignant neoplasm of skin", "shape": "dot", "title": "Malignant neoplasm of skin"}, {"group": 3, "id": "Non-Small Cell Lung Carcinoma", "label": "Non-Small Cell Lung Carcinoma", "shape": "dot", "title": "Non-Small Cell Lung Carcinoma"}, {"group": 3, "id": "Squamous cell carcinoma", "label": "Squamous cell carcinoma", "shape": "dot", "title": "Squamous cell carcinoma"}, {"group": 3, "id": "Carotid Stenosis", "label": "Carotid Stenosis", "shape": "dot", "title": "Carotid Stenosis"}, {"group": 3, "id": "Cerebral Infarction", "label": "Cerebral Infarction", "shape": "dot", "title": "Cerebral Infarction"}, {"group": 3, "id": "Malignant tumor of cervix", "label": "Malignant tumor of cervix", "shape": "dot", "title": "Malignant tumor of cervix"}, {"group": 3, "id": "Colorectal Carcinoma", "label": "Colorectal Carcinoma", "shape": "dot", "title": "Colorectal Carcinoma"}, {"group": 3, "id": "Coronary heart disease", "label": "Coronary heart disease", "shape": "dot", "title": "Coronary heart disease"}, {"group": 3, "id": "Dermatitis, Atopic", "label": "Dermatitis, Atopic", "shape": "dot", "title": "Dermatitis, Atopic"}, {"group": 3, "id": "Diabetes Mellitus, Non-Insulin-Dependent", "label": "Diabetes Mellitus, Non-Insulin-Dependent", "shape": "dot", "title": "Diabetes Mellitus, Non-Insulin-Dependent"}, {"group": 3, "id": "Diabetic Angiopathies", "label": "Diabetic Angiopathies", "shape": "dot", "title": "Diabetic Angiopathies"}, {"group": 3, "id": "Diabetic Nephropathy", "label": "Diabetic Nephropathy", "shape": "dot", "title": "Diabetic Nephropathy"}, {"group": 3, "id": "Dysmenorrhea", "label": "Dysmenorrhea", "shape": "dot", "title": "Dysmenorrhea"}, {"group": 3, "id": "Endometrial Neoplasms", "label": "Endometrial Neoplasms", "shape": "dot", "title": "Endometrial Neoplasms"}, {"group": 3, "id": "Epilepsy", "label": "Epilepsy", "shape": "dot", "title": "Epilepsy"}, {"group": 3, "id": "Fibromuscular Dysplasia", "label": "Fibromuscular Dysplasia", "shape": "dot", "title": "Fibromuscular Dysplasia"}, {"group": 3, "id": "Foot-and-Mouth Disease", "label": "Foot-and-Mouth Disease", "shape": "dot", "title": "Foot-and-Mouth Disease"}, {"group": 3, "id": "Hamartoma Syndrome, Multiple", "label": "Hamartoma Syndrome, Multiple", "shape": "dot", "title": "Hamartoma Syndrome, Multiple"}, {"group": 3, "id": "Hay fever", "label": "Hay fever", "shape": "dot", "title": "Hay fever"}, {"group": 3, "id": "Hepatitis B", "label": "Hepatitis B", "shape": "dot", "title": "Hepatitis B"}, {"group": 3, "id": "Hepatitis C", "label": "Hepatitis C", "shape": "dot", "title": "Hepatitis C"}, {"group": 3, "id": "Herpesviridae Infections", "label": "Herpesviridae Infections", "shape": "dot", "title": "Herpesviridae Infections"}, {"group": 3, "id": "HIV Infections", "label": "HIV Infections", "shape": "dot", "title": "HIV Infections"}, {"group": 3, "id": "Hypercholesterolemia", "label": "Hypercholesterolemia", "shape": "dot", "title": "Hypercholesterolemia"}, {"group": 3, "id": "Hypertensive disease", "label": "Hypertensive disease", "shape": "dot", "title": "Hypertensive disease"}, {"group": 3, "id": "Inflammatory Bowel Diseases", "label": "Inflammatory Bowel Diseases", "shape": "dot", "title": "Inflammatory Bowel Diseases"}, {"group": 3, "id": "Influenza", "label": "Influenza", "shape": "dot", "title": "Influenza"}, {"group": 3, "id": "Kidney Diseases", "label": "Kidney Diseases", "shape": "dot", "title": "Kidney Diseases"}, {"group": 3, "id": "Acute Megakaryocytic Leukemias", "label": "Acute Megakaryocytic Leukemias", "shape": "dot", "title": "Acute Megakaryocytic Leukemias"}, {"group": 3, "id": "Listeriosis", "label": "Listeriosis", "shape": "dot", "title": "Listeriosis"}, {"group": 3, "id": "Chronic Obstructive Airway Disease", "label": "Chronic Obstructive Airway Disease", "shape": "dot", "title": "Chronic Obstructive Airway Disease"}, {"group": 3, "id": "Lung Neoplasms", "label": "Lung Neoplasms", "shape": "dot", "title": "Lung Neoplasms"}, {"group": 3, "id": "Lupus Erythematosus, Systemic", "label": "Lupus Erythematosus, Systemic", "shape": "dot", "title": "Lupus Erythematosus, Systemic"}, {"group": 3, "id": "Malignant neoplasm of stomach", "label": "Malignant neoplasm of stomach", "shape": "dot", "title": "Malignant neoplasm of stomach"}, {"group": 3, "id": "Mouth Neoplasms", "label": "Mouth Neoplasms", "shape": "dot", "title": "Mouth Neoplasms"}, {"group": 3, "id": "Mycoplasma Infections", "label": "Mycoplasma Infections", "shape": "dot", "title": "Mycoplasma Infections"}, {"group": 3, "id": "Oral Submucous Fibrosis", "label": "Oral Submucous Fibrosis", "shape": "dot", "title": "Oral Submucous Fibrosis"}, {"group": 3, "id": "Parasitic Diseases", "label": "Parasitic Diseases", "shape": "dot", "title": "Parasitic Diseases"}, {"group": 3, "id": "Periodontitis", "label": "Periodontitis", "shape": "dot", "title": "Periodontitis"}, {"group": 3, "id": "Conventional (Clear Cell) Renal Cell Carcinoma", "label": "Conventional (Clear Cell) Renal Cell Carcinoma", "shape": "dot", "title": "Conventional (Clear Cell) Renal Cell Carcinoma"}, {"group": 3, "id": "Schistosomiasis", "label": "Schistosomiasis", "shape": "dot", "title": "Schistosomiasis"}, {"group": 3, "id": "Schizophrenia", "label": "Schizophrenia", "shape": "dot", "title": "Schizophrenia"}, {"group": 3, "id": "Septicemia", "label": "Septicemia", "shape": "dot", "title": "Septicemia"}, {"group": 3, "id": "Smoking", "label": "Smoking", "shape": "dot", "title": "Smoking"}, {"group": 3, "id": "Stomach Neoplasms", "label": "Stomach Neoplasms", "shape": "dot", "title": "Stomach Neoplasms"}, {"group": 3, "id": "Cerebrovascular accident", "label": "Cerebrovascular accident", "shape": "dot", "title": "Cerebrovascular accident"}, {"group": 3, "id": "Ocular Toxoplasmosis", "label": "Ocular Toxoplasmosis", "shape": "dot", "title": "Ocular Toxoplasmosis"}, {"group": 3, "id": "Uveitis", "label": "Uveitis", "shape": "dot", "title": "Uveitis"}, {"group": 3, "id": "Vascular Diseases", "label": "Vascular Diseases", "shape": "dot", "title": "Vascular Diseases"}, {"group": 3, "id": "Virus Diseases", "label": "Virus Diseases", "shape": "dot", "title": "Virus Diseases"}, {"group": 3, "id": "Alopecia", "label": "Alopecia", "shape": "dot", "title": "Alopecia"}, {"group": 3, "id": "Arteriosclerosis", "label": "Arteriosclerosis", "shape": "dot", "title": "Arteriosclerosis"}, {"group": 3, "id": "Rheumatoid Arthritis", "label": "Rheumatoid Arthritis", "shape": "dot", "title": "Rheumatoid Arthritis"}, {"group": 3, "id": "Asthma", "label": "Asthma", "shape": "dot", "title": "Asthma"}, {"group": 3, "id": "Atherosclerosis", "label": "Atherosclerosis", "shape": "dot", "title": "Atherosclerosis"}, {"group": 3, "id": "Bacterial Infections", "label": "Bacterial Infections", "shape": "dot", "title": "Bacterial Infections"}, {"group": 3, "id": "Brain Neoplasms", "label": "Brain Neoplasms", "shape": "dot", "title": "Brain Neoplasms"}, {"group": 3, "id": "Gestational Diabetes", "label": "Gestational Diabetes", "shape": "dot", "title": "Gestational Diabetes"}, {"group": 3, "id": "Hepatitis E", "label": "Hepatitis E", "shape": "dot", "title": "Hepatitis E"}, {"group": 3, "id": "Left Ventricular Hypertrophy", "label": "Left Ventricular Hypertrophy", "shape": "dot", "title": "Left Ventricular Hypertrophy"}, {"group": 3, "id": "Small cell carcinoma of lung", "label": "Small cell carcinoma of lung", "shape": "dot", "title": "Small cell carcinoma of lung"}, {"group": 3, "id": "Active tuberculosis", "label": "Active tuberculosis", "shape": "dot", "title": "Active tuberculosis"}, {"group": 3, "id": "Cutaneous Melanoma", "label": "Cutaneous Melanoma", "shape": "dot", "title": "Cutaneous Melanoma"}, {"group": 3, "id": "Adenocarcinoma of lung (disorder)", "label": "Adenocarcinoma of lung (disorder)", "shape": "dot", "title": "Adenocarcinoma of lung (disorder)"}, {"group": 3, "id": "Malignant neoplasm of mouth", "label": "Malignant neoplasm of mouth", "shape": "dot", "title": "Malignant neoplasm of mouth"}, {"group": 3, "id": "Malignant neoplasm of brain", "label": "Malignant neoplasm of brain", "shape": "dot", "title": "Malignant neoplasm of brain"}, {"group": 3, "id": "Secondary malignant neoplasm of lung", "label": "Secondary malignant neoplasm of lung", "shape": "dot", "title": "Secondary malignant neoplasm of lung"}, {"group": 3, "id": "Acute myocardial infarction", "label": "Acute myocardial infarction", "shape": "dot", "title": "Acute myocardial infarction"}, {"group": 3, "id": "Prion Diseases", "label": "Prion Diseases", "shape": "dot", "title": "Prion Diseases"}, {"group": 3, "id": "Right Ventricular Hypertrophy", "label": "Right Ventricular Hypertrophy", "shape": "dot", "title": "Right Ventricular Hypertrophy"}, {"group": 3, "id": "Aortic Aneurysm, Abdominal", "label": "Aortic Aneurysm, Abdominal", "shape": "dot", "title": "Aortic Aneurysm, Abdominal"}, {"group": 3, "id": "Inflammatory disease of the central nervous system", "label": "Inflammatory disease of the central nervous system", "shape": "dot", "title": "Inflammatory disease of the central nervous system"}, {"group": 3, "id": "Cerebral Hypoxia-Ischemia", "label": "Cerebral Hypoxia-Ischemia", "shape": "dot", "title": "Cerebral Hypoxia-Ischemia"}, {"group": 3, "id": "Cholangiocarcinoma", "label": "Cholangiocarcinoma", "shape": "dot", "title": "Cholangiocarcinoma"}, {"group": 3, "id": "Metastatic malignant neoplasm to brain", "label": "Metastatic malignant neoplasm to brain", "shape": "dot", "title": "Metastatic malignant neoplasm to brain"}, {"group": 3, "id": "Congenital contractural arachnodactyly", "label": "Congenital contractural arachnodactyly", "shape": "dot", "title": "Congenital contractural arachnodactyly"}, {"group": 3, "id": "Muscular Dystrophy, Facioscapulohumeral", "label": "Muscular Dystrophy, Facioscapulohumeral", "shape": "dot", "title": "Muscular Dystrophy, Facioscapulohumeral"}, {"group": 3, "id": "Dyslipidemias", "label": "Dyslipidemias", "shape": "dot", "title": "Dyslipidemias"}, {"group": 3, "id": "Sepsis", "label": "Sepsis", "shape": "dot", "title": "Sepsis"}, {"group": 3, "id": "Dilatation of aorta", "label": "Dilatation of aorta", "shape": "dot", "title": "Dilatation of aorta"}, {"group": 3, "id": "Endometrioma", "label": "Endometrioma", "shape": "dot", "title": "Endometrioma"}, {"group": 3, "id": "Solid Neoplasm", "label": "Solid Neoplasm", "shape": "dot", "title": "Solid Neoplasm"}, {"group": 3, "id": "Cervix carcinoma", "label": "Cervix carcinoma", "shape": "dot", "title": "Cervix carcinoma"}, {"group": 3, "id": "Early gastric cancer", "label": "Early gastric cancer", "shape": "dot", "title": "Early gastric cancer"}, {"group": 3, "id": "Endometrial Carcinoma", "label": "Endometrial Carcinoma", "shape": "dot", "title": "Endometrial Carcinoma"}, {"group": 3, "id": "Refractory cancer", "label": "Refractory cancer", "shape": "dot", "title": "Refractory cancer"}, {"group": 3, "id": "Secondary malignant neoplasm of lymph node", "label": "Secondary malignant neoplasm of lymph node", "shape": "dot", "title": "Secondary malignant neoplasm of lymph node"}, {"group": 3, "id": "Stomach Carcinoma", "label": "Stomach Carcinoma", "shape": "dot", "title": "Stomach Carcinoma"}, {"group": 3, "id": "Acute Chest Syndrome", "label": "Acute Chest Syndrome", "shape": "dot", "title": "Acute Chest Syndrome"}, {"group": 3, "id": "Acute Cerebrovascular Accidents", "label": "Acute Cerebrovascular Accidents", "shape": "dot", "title": "Acute Cerebrovascular Accidents"}, {"group": 3, "id": "Pregnancy associated hypertension", "label": "Pregnancy associated hypertension", "shape": "dot", "title": "Pregnancy associated hypertension"}, {"group": 3, "id": "ovarian neoplasm", "label": "ovarian neoplasm", "shape": "dot", "title": "ovarian neoplasm"}, {"group": 3, "id": "Malignant neoplasm of ovary", "label": "Malignant neoplasm of ovary", "shape": "dot", "title": "Malignant neoplasm of ovary"}, {"group": 3, "id": "Severe Acute Respiratory Syndrome", "label": "Severe Acute Respiratory Syndrome", "shape": "dot", "title": "Severe Acute Respiratory Syndrome"}, {"group": 3, "id": "Attention deficit hyperactivity disorder", "label": "Attention deficit hyperactivity disorder", "shape": "dot", "title": "Attention deficit hyperactivity disorder"}, {"group": 3, "id": "Inflammatory disorder", "label": "Inflammatory disorder", "shape": "dot", "title": "Inflammatory disorder"}, {"group": 3, "id": "Smoking Behaviors", "label": "Smoking Behaviors", "shape": "dot", "title": "Smoking Behaviors"}, {"group": 3, "id": "ST segment elevation myocardial infarction", "label": "ST segment elevation myocardial infarction", "shape": "dot", "title": "ST segment elevation myocardial infarction"}, {"group": 3, "id": "Latent Tuberculosis", "label": "Latent Tuberculosis", "shape": "dot", "title": "Latent Tuberculosis"}, {"group": 3, "id": "Hereditary Diffuse Gastric Cancer", "label": "Hereditary Diffuse Gastric Cancer", "shape": "dot", "title": "Hereditary Diffuse Gastric Cancer"}, {"group": 3, "id": "ANOPHTHALMIA AND PULMONARY HYPOPLASIA", "label": "ANOPHTHALMIA AND PULMONARY HYPOPLASIA", "shape": "dot", "title": "ANOPHTHALMIA AND PULMONARY HYPOPLASIA"}, {"group": 3, "id": "Coronary Artery Disease", "label": "Coronary Artery Disease", "shape": "dot", "title": "Coronary Artery Disease"}, {"group": 3, "id": "Low grade glioma", "label": "Low grade glioma", "shape": "dot", "title": "Low grade glioma"}, {"group": 3, "id": "Chronic thromboembolic pulmonary hypertension", "label": "Chronic thromboembolic pulmonary hypertension", "shape": "dot", "title": "Chronic thromboembolic pulmonary hypertension"}, {"group": 3, "id": "Acute pulmonary embolism", "label": "Acute pulmonary embolism", "shape": "dot", "title": "Acute pulmonary embolism"}, {"group": 3, "id": "Nasopharyngeal carcinoma", "label": "Nasopharyngeal carcinoma", "shape": "dot", "title": "Nasopharyngeal carcinoma"}, {"group": 3, "id": "Peri-Implantitis", "label": "Peri-Implantitis", "shape": "dot", "title": "Peri-Implantitis"}, {"group": 3, "id": "Secondary Neoplasm", "label": "Secondary Neoplasm", "shape": "dot", "title": "Secondary Neoplasm"}, {"group": 3, "id": "Pulmonary arterial hypertension", "label": "Pulmonary arterial hypertension", "shape": "dot", "title": "Pulmonary arterial hypertension"}, {"group": 3, "id": "Idiopathic pulmonary arterial hypertension", "label": "Idiopathic pulmonary arterial hypertension", "shape": "dot", "title": "Idiopathic pulmonary arterial hypertension"}, {"group": 3, "id": "Middle East Respiratory Syndrome", "label": "Middle East Respiratory Syndrome", "shape": "dot", "title": "Middle East Respiratory Syndrome"}, {"group": 3, "id": "Infection", "label": "Infection", "shape": "dot", "title": "Infection"}, {"group": 3, "id": "Skin Erosion", "label": "Skin Erosion", "shape": "dot", "title": "Skin Erosion"}, {"group": 3, "id": "cervical cancer", "label": "cervical cancer", "shape": "dot", "title": "cervical cancer"}, {"group": 3, "id": "FRONTOMETAPHYSEAL DYSPLASIA 1", "label": "FRONTOMETAPHYSEAL DYSPLASIA 1", "shape": "dot", "title": "FRONTOMETAPHYSEAL DYSPLASIA 1"}, {"group": 3, "id": "Carcinoma, Ovarian Epithelial", "label": "Carcinoma, Ovarian Epithelial", "shape": "dot", "title": "Carcinoma, Ovarian Epithelial"}]);
                  edges = new vis.DataSet([{"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00864", "title": "Tacrolimus may increase the nephrotoxic activities of Cyclosporine.", "to": "DB00091"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00091", "title": "binder", "to": "CAMLG"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00091", "title": "binder", "to": "CAML"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00091", "title": "binder", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00091", "title": "inhibitor", "to": "PPP3R2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00091", "title": "inhibitor", "to": "CBLP"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00091", "title": "inhibitor", "to": "PPP3RL"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00091", "title": "inhibitor", "to": "PPIA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00091", "title": "inhibitor", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00091", "title": "binder", "to": "PPIA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00091", "title": "binder", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00091", "title": "binder", "to": "PPIF"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00091", "title": "binder", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00864", "title": "inhibitor", "to": "FKBP1A"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00864", "title": "inhibitor", "to": "FKBP1"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "DB00864", "title": "inhibitor", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "PPP3RL", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "PPP3RL", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "FKBP12", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "FKBP12", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "CYP3", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Degenerative polyarthritis", "title": "Moreover, we found that surgical-induced OA mice treated with a miR-146a inhibitor significantly alleviated the destruction of articular cartilage via targeting Camk2d and Ppp3r2.", "to": "PPP3RL"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Asthenozoospermia", "title": "We demonstrate herein that male mice lacking Ppp3cc or Ppp3r2 genes (knockout mice) are infertile, with reduced sperm motility owing to an inflexible midpiece.", "to": "PPP3RL"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Renal Cell Carcinoma", "title": "Therefore, a full-length FKBP-12 cDNA was PCR-cloned from the lambda gt 11 renal carcinoma cDNA library and was subcloned into an expression vector.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Infection by Cryptococcus neoformans", "title": "Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 in Cryptococcus neoformans.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Infection by Cryptococcus neoformans", "title": "Here we report the crystal structures of calcineurin catalytic (CnA) and regulatory (CnB) subunits complexed with FK506 and the FK506-binding protein (FKBP12) from human fungal pathogens (Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans and Coccidioides immitis).", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Scleroderma", "title": "Furthermore, FKBP12, which protects TGFbeta receptor type I from ligand-independent activation by TGFbeta receptor type II, constitutively dissociated from TGFbeta receptor type I in scleroderma fibroblasts.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Esophageal Neoplasms", "title": "Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Fibrodysplasia Ossificans Progressiva", "title": "Although Activin-A increased activation of the pSMAD3 pathway in both control and FOP PLF, it increased ACVR1, FK binding protein 12 (FKBP12), an inhibitor of DNA binding 1 protein (ID-1) expression only in FOP PLF.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Fibrodysplasia Ossificans Progressiva", "title": "In vitro analyses of the dysregulated R206H ALK2 kinase-FKBP12 interaction associated with heterotopic ossification in FOP.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Fibrodysplasia Ossificans Progressiva", "title": "Taken together, FKBP12 binds to and suppresses mutant ALK2 proteins associated with FOP and DIPG, except for PF197-8L.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Graves Disease", "title": "The frequency of IgG and/or IgM anti-FKBP12 autoantibodies detected by ELISA was as follows; SLE (15/39), SSc (11/27), CREST (4/7), RA (2/8), MCTD (0/5), Graves\u0027 disease (4/12), IDDM (2/6), PM/DM (0/3), MG (1/4), AIH (2/6), PBC (4/9), and healthy subjects (5/118).", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Heart failure", "title": "Ryanodine receptors, FKBP12, and heart failure.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Congestive heart failure", "title": "Ryanodine receptors, FKBP12, and heart failure.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Liver Cirrhosis, Experimental", "title": "Systems level analysis and identification of pathways and networks associated with liver fibrosis.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Lymphoma", "title": "In the presence of rapamycin, immobilized GST-FKBP12 specifically precipitates similar high molecular mass proteins from both rat brain and murine T-lymphoma cell extracts.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "To optimize FKBP/Rapa for subcutaneous (SC) administration, this manuscript expands upon first-generation FSI nanoparticles (\u003ci\u003eR\u003csub\u003eh\u003c/sub\u003e\u003c/i\u003e ~ 25 nm) and compares them with two second-generation carriers (FA and FAF) that: i) do not self-assemble; ii) retain a hydrodynamic radius (\u003ci\u003eR\u003csub\u003eh\u003c/sub\u003e\u003c/i\u003e ~ 7 nm) above the renal filtration cutoff; iii) increase tumor accumulation; and iv) have either one (FA) or two (FAF) drug-binding FKBP domains per ELP protein.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "We recently reported that the fusion of FK-506 binding protein 12 (FKBP) to an ELP nanoparticle (FSI) increases rapamycin (Rapa) solubility, suppresses tumor growth in breast cancer xenografts, and reduces side effects observed with free-drug controls.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Parkinson Disease", "title": "In this study, we found that FKBP12 colocalized with \u03b1-SYN in LBs and neurites in PD and DLB brains.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Parkinson Disease", "title": "The PPIase CypA colocalizes with the Parkinson\u0027s disease (PD)-associated protein\u00a0 \u03b1 -synuclein in cells and interacts with\u00a0 \u03b1 -synuclein oligomers.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Parkinson Disease", "title": "Thus, FKBP12 can endogenously regulate calcineurin activity with therapeutic implications for the treatment of PD.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Parkinson Disease", "title": "Both in vitro and cell culture data provide strong evidence that FKBP12 is the most important PPIase modulating \u03b1-SYN aggregation and validate the protein as an interesting drug target for Parkinson disease.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Plasmacytoma", "title": "Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Systemic Scleroderma", "title": "Furthermore, FKBP12, which protects TGFbeta receptor type I from ligand-independent activation by TGFbeta receptor type II, constitutively dissociated from TGFbeta receptor type I in scleroderma fibroblasts.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Dermatologic disorders", "title": "We have previously developed an \u003ci\u003eAgrobacterium tumefaciens\u003c/i\u003e transformation system effective for both targeted gene deletion and insertional mutagenesis in \u003ci\u003eMalassezia furfur\u003c/i\u003e and \u003ci\u003eM. sympodialis\u003c/i\u003e In the present study, these molecular resources were applied to characterize the immunophilin FKBP12 as the target of tacrolimus (FK506), ascomycin, and pimecrolimus, which are calcineurin inhibitors that are used as alternatives to corticosteroids in the treatment of inflammatory skin disorders such as those associated with \u003ci\u003eMalassezia\u003c/i\u003e species.While \u003ci\u003eM. furfur\u003c/i\u003e and \u003ci\u003eM. sympodialis\u003c/i\u003e showed \u003ci\u003ein vitro\u003c/i\u003e sensitivity to these agents, \u003ci\u003efkb1\u003c/i\u003e\u0394 mutants displayed full resistance to all three of them, confirming that FKBP12 is the target of these calcineurin inhibitors and is essential for their activity.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Dermatologic disorders", "title": "These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-\u03baB and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Stomach Diseases", "title": "Our results provided insight on the protein interaction networks and signaling pathways that may contribute to PPIase-FKBP-associated gastric diseases and may lead to a better understanding of the mechanisms indicating the oncogenic effects of H. pylori PPIase-FKBP.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Abscess", "title": "Previously, we identified two PPIase enzymes in \u003ci\u003eStaphylococcus aureus\u003c/i\u003e (PpiB and PrsA) that are involved in the regulation of virulence determinants and have shown that PpiB contributes to \u003ci\u003eS. aureus\u003c/i\u003e virulence in a murine abscess model of infection.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Alzheimer\u0027s Disease", "title": "Importantly, by up-regulating mTOR signaling, glycogen synthase kinase 3 (GSK3) inhibitors rescued LTP in the AD mouse model, and genetic deletion of FK506-binding protein 12 (FKBP12) prevented A\u03b2-induced impairment in long-term potentiation (LTP).", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Alzheimer\u0027s Disease", "title": "To elucidate the roles of FKBP12 in the pathogenesis of Alzheimer\u0027s disease, the effect of FKBP12 overexpression on APP processing was evaluated.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Atrial Fibrillation", "title": "Spontaneous AF was documented by telemetry in vivo and Langendorff-perfused hearts of \u03b1MyHC-FKBP12 and littermate control mice in vitro.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Autoimmune Diseases", "title": "Autoantibodies to FK506 binding protein 12 (FKBP12) in autoimmune diseases.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Bipolar Disorder", "title": "This finding suggests that IP(3)R1 dysfunction through the FKBP12 binding site is not involved in the pathogenesis of bipolar disorder.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Bipolar Disorder", "title": "The present study tests the hypothesis that dysfunction of calcium mobilization in bipolar disorder is due to the mutation of the nucleotide sequence in the FKBP12 binding site on the inositol 1,4,5-trisphosphate type-1 receptor (IP(3)R1).", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of breast", "title": "We recently reported that the fusion of FK-506 binding protein 12 (FKBP) to an ELP nanoparticle (FSI) increases rapamycin (Rapa) solubility, suppresses tumor growth in breast cancer xenografts, and reduces side effects observed with free-drug controls.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of breast", "title": "We recently reported that fusion of the FK-506 binding protein 12 (FKBP) to an ELP nanoparticle (FSI) reduces rapamycin (Rapa) toxicity and enables intravenous (IV) therapy in both a xenograft breast cancer model and a murine autoimmune disease model.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of breast", "title": "FKBP12 is a predictive biomarker for efficacy of anthracycline-based chemotherapy in breast cancer.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "These include the FKBP12-rapamycin-binding proteins Tor1p, Tor2p, and FRAP, S. pombe rad3, and the product of the ataxia telangiectasia gene, mutations in which lead to genomic instability and predisposition to cancer.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Motor Neuron Disease", "title": "The anterior horn neurons of MND cases of short clinical duration showed absent IR to FKBP 12 antibody but present IR to RyR (type 1 and 2) antibodies.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Arthritis aggravated", "title": "Our findings provide evidence that PPIase CypA promoted macrophages polarization toward pro-inflammatory M1 phenotype via transcriptional activating NF-\u03baB, thus leading to aggravated arthritis.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Parkinsonian Disorders", "title": "Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson\u0027s disease and identification of FKBP-12-binding proteins.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Systemic Inflammatory Response Syndrome", "title": "In this study, we found that FKBP12 acts as a novel target protein in mediating necroptosis and the related systemic inflammatory response syndrome triggered by TNF.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Simple renal cyst", "title": "These results suggest that PEP-1-FK506BP delayed cyst formation and could be a new therapeutic strategy for renal cyst formation in PKD.[BMB Reports 2017; 50(9): 460-465].", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Muscular Dystrophy, Oculopharyngeal", "title": "In addition, CUGBP1, SFRS3, and FKBP1A were also found in OPMD muscle INIs.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Squamous cell carcinoma of esophagus", "title": "Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of prostate", "title": "The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Alzheimer Disease, Late Onset", "title": "For HPA involvement, a CRHR1 haplotype with MAPT was described, but further association of only HSD11B1 with LOAD found; however, association of FKBP1 and NC3R1 polymorphisms was documented in support of stress influence to LOAD.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "3-Methylglutaconic aciduria type 2", "title": "Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "3-Methylglutaconic aciduria type 2", "title": "We here describe the genetic background of this disorder: some of the most mutated genes that are responsible for the disease are (G4.5 (tafazzin gene): alpha-dystrobrevin gene (DTNA); FKBP-12 gene; lamin A/C gene; Cypher/ZASP (LIM, LDB3) gene); and some genotype-phenotype correlations (Becker muscular dystrophy, Emery-Dreifuss muscular dystrophy or Barth syndrome) based on the literature review.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Prostate carcinoma", "title": "The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Breast Carcinoma", "title": "Using IHC (IHC) with antibodies to FKBP12 on breast carcinomas we found that FKBP12 localizes to breast tumor vasculature.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Breast Carcinoma", "title": "We recently reported that fusion of the FK-506 binding protein 12 (FKBP) to an ELP nanoparticle (FSI) reduces rapamycin (Rapa) toxicity and enables intravenous (IV) therapy in both a xenograft breast cancer model and a murine autoimmune disease model.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Breast Carcinoma", "title": "FKBP12 is a predictive biomarker for efficacy of anthracycline-based chemotherapy in breast cancer.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Breast Carcinoma", "title": "We recently reported that the fusion of FK-506 binding protein 12 (FKBP) to an ELP nanoparticle (FSI) increases rapamycin (Rapa) solubility, suppresses tumor growth in breast cancer xenografts, and reduces side effects observed with free-drug controls.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Central Core Myopathy (disorder)", "title": "We also sequenced two genes encoding RYR1-associated proteins as candidate causative genes for CCD: the 12 kD FK506-binding protein (FKBP12) and the alpha1 subunit of L-type voltage-dependent calcium channel or dihydropyridine receptor (CACNA1S).", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Lewy Body Disease", "title": "Furthermore, FKBP12-immunopositive neurofibrillary tangles colocalized with phosphorylated tau in DLB and FKBP12-immunopositive glial cytoplasmic inclusions colocalized with \u03b1-SYN in MSA.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Invasive carcinoma of breast", "title": "An immunohistochemical analysis of FKBP12 expression was performed in a cohort of 524 patients with invasive breast cancer.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "These include the FKBP12-rapamycin-binding proteins Tor1p, Tor2p, and FRAP, S. pombe rad3, and the product of the ataxia telangiectasia gene, mutations in which lead to genomic instability and predisposition to cancer.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Adult Lymphoma", "title": "In the presence of rapamycin, immobilized GST-FKBP12 specifically precipitates similar high molecular mass proteins from both rat brain and murine T-lymphoma cell extracts.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Childhood Lymphoma", "title": "In the presence of rapamycin, immobilized GST-FKBP12 specifically precipitates similar high molecular mass proteins from both rat brain and murine T-lymphoma cell extracts.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Renal carcinoma", "title": "Therefore, a full-length FKBP-12 cDNA was PCR-cloned from the lambda gt 11 renal carcinoma cDNA library and was subcloned into an expression vector.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Mammary Neoplasms", "title": "Using IHC (IHC) with antibodies to FKBP12 on breast carcinomas we found that FKBP12 localizes to breast tumor vasculature.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "AMYOTROPHIC LATERAL SCLEROSIS 1", "title": "These data suggest that mutant SOD produces a greater need for rotamase and, also, highlights possible new therapeutic strategies in FALS.", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Renal cyst", "title": "These results suggest that PEP-1-FK506BP delayed cyst formation and could be a new therapeutic strategy for renal cyst formation in PKD.[BMB Reports 2017; 50(9): 460-465].", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Episodic Kinesigenic Dyskinesia 1", "title": "These results suggest that PEP-1-FK506BP delayed cyst formation and could be a new therapeutic strategy for renal cyst formation in PKD.[BMB Reports 2017; 50(9): 460-465].", "to": "FKBP12"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant tumor of colon", "title": "This study aims to assess the effects of GAD on the energy metabolism of colon cancer through the regulation of SIRT3 expression and whether this effect is related to acetylated cyclophilin D. The results demonstrated that GAD inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cardiovascular Diseases", "title": "A greater understanding of the physiologic functions of the MPTP and its regulation by CypD will likely suggest novel therapeutic approaches for cardiovascular disease, both dependent and independent of programmed necrotic cell death mechanisms.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary Arteriosclerosis", "title": "Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection?", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes", "title": "We tested the hypothesis of whether NMDA-R1 mediates Ca\u003csup\u003e2+\u003c/sup\u003e influx causing CypD activation and MPTP opening leading to oxidative stress and renal injury in diabetes.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes", "title": "Brains from mice with STZ-induced diabetes revealed a significant increase of cyclophilin D (CypD) expression, reduced respiratory function, and decreased hippocampal long-term potentiation (LTP); these animals had impaired spatial learning and memory.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes", "title": "Targeting cyclophilin D and the mitochondrial permeability transition enhances beta-cell survival and prevents diabetes in Pdx1 deficiency.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes Mellitus", "title": "Targeting cyclophilin D and the mitochondrial permeability transition enhances beta-cell survival and prevents diabetes in Pdx1 deficiency.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes Mellitus", "title": "Brains from mice with STZ-induced diabetes revealed a significant increase of cyclophilin D (CypD) expression, reduced respiratory function, and decreased hippocampal long-term potentiation (LTP); these animals had impaired spatial learning and memory.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes Mellitus", "title": "We tested the hypothesis of whether NMDA-R1 mediates Ca\u003csup\u003e2+\u003c/sup\u003e influx causing CypD activation and MPTP opening leading to oxidative stress and renal injury in diabetes.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Muscular Dystrophy, Duchenne", "title": "Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Encephalomyelitis", "title": "Analysis of mitochondrial calcium retention capacity and the course of EAE in cyclophilin D knockout mice indicated that the effect of NIM811 on EAE was not entirely cyclophilin D-dependent.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Fatty Liver", "title": "As such, CypD might be a new protective target against I/RI in fatty livers.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Fatty Liver", "title": "Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Glioblastoma", "title": "Significantly, we provide evidence that CYPD-mediated opening of the mPTP is required for gossypol-induced mitochondrial dysfunction, autophagy and cell death during organismic aging of P. anserina and in glioblastoma cells.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Glioma", "title": "Blockade of Cyp-D by siRNA-mediated depletion or pharmacological inhibitors (cyclosporin A and sanglifehrin A) significantly suppressed salinomycin-induced glioma cell necrosis.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Heart failure", "title": "Since obesity and metabolic syndrome decrease SIRT3 activity and expression, we tested the hypothesis that CypD hyperacetylation promotes mitochondrial dysfunction under this pathophysiological state, which is associated with ventricular dysfunction and heart failure.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Congestive heart failure", "title": "Since obesity and metabolic syndrome decrease SIRT3 activity and expression, we tested the hypothesis that CypD hyperacetylation promotes mitochondrial dysfunction under this pathophysiological state, which is associated with ventricular dysfunction and heart failure.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hyperglycemia", "title": "Hyperglycemia exacerbated the upregulation of CypD, mitochondrial defects, synaptic injury, and cognitive dysfunction in the brains of transgenic AD mice overexpressing amyloid-\u03b2 as shown by decreased mitochondrial respiratory complex I and IV enzyme activity and greatly decreased mitochondrial respiratory rate.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Intestinal Diseases", "title": "We then targeted mitochondrial cyclophilin D (CypD), a key regulator of the mPT, in a mouse model of NSAID enteropathy.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Kidney Failure, Acute", "title": "Mitochondrial translocation of PPAR\u03b1, its binding to cyclophilin D, and sequestration led to inhibition of its nuclear translocation and transcription of PPAR\u03b1-regulated fatty acid oxidation genes during cisplatin-induced acute kidney injury.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Kidney Failure, Acute", "title": "p53-cyclophilin D mediates renal tubular cell apoptosis in ischemia-reperfusion-induced acute kidney injury.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Kidney Failure, Acute", "title": "Cyclophilin D (CypD) is an important component in mitochondrial-dependent tubular cell death in acute kidney injury.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Acute lymphocytic leukemia", "title": "CYP3 genotypes may not significantly modify the risk of relapse in childhood ALL, but may modify the risk of toxicity.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Meningioma", "title": "We report that cyclophilin D levels were upregulated in all grades of human meningioma compared to control meninges.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Myopathy", "title": "These findings (i) demonstrate that lack of Cyp-D is equivalent to its inhibition with CsA at curing the mouse dystrophic phenotype; (ii) establish a cause-effect relationship between Cyp-D-dependent PTP regulation and pathogenesis of the ColVI muscular dystrophy and (iii) validate Cyp-D and the PTP as pharmacological targets for the therapy of human ColVI myopathies.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Muscular Dystrophy", "title": "Here we show that deletion of the gene encoding cyclophilin D (Ppif) rendered mitochondria largely insensitive to the calcium overload-induced swelling associated with a defective sarcolemma, thus reducing myofiber necrosis in two distinct models of muscular dystrophy.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Myocardial Infarction", "title": "Most animal studies demonstrated cardioprotective effects of PTP inhibition; however, a recent large clinical trial conducted by international groups demonstrated that cyclosporine A, a cyclophilin D inhibitor, failed to protect the heart in patients with myocardial infarction.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "Among its distribution Hsp90 is also localized within mitochondria of neoplastic cells of various origin, interacting with another chaperone, TRAP1 (Tumor necrosis factor type 1 receptor-associated protein or Heat-shock-protein 75) to antagonize the cell death promoting properties of the matrix protein, Cyclophilin-D. Several preclinical studies, including in vivo studies in both orthotopic and genetic animal models, have confirmed that targeting mitochondrial Hsp90 may be a novel efficient treatment method for highly recalcitrant tumors.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Nephrotic Syndrome", "title": "Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Obesity", "title": "Our results indicate that obesity reduces SIRT3 expression and that CypD hyperacetylation increases mPTP opening, suggesting that the activation of SIRT3 might be a potential target to decrease ventricular dysfunction and slow the progression of heart failure.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Pancreatitis", "title": "\u2022Pancreatitis-inducing factors open the membrane transition pore (mPTP) channel via cyclophilin D activation in acinar cells, causing calcium overload and cell death; genetic or pharmacological inhibition of mPTP improves the outcome of acute pancreatitis in animal models.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Pancreatitis", "title": "In particular, the pathway involving enhanced interaction of cyclophilin D with ATP synthase mediates L-arginine-induced pancreatitis, a model of severe AP the pathogenesis of which has remained unknown.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Parkinson Disease", "title": "We investigated the role of CYPD in a mouse model of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced PD.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Parkinson Disease", "title": "In conclusion, these results suggest Cyp1 and its human homolog CypD as putative molecular targets for the treatment of DJ-1 deficiency-associated diseases, including Parkinson\u0027s disease.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Tuberculosis", "title": "Similarly, the cyclophilin D-inhibiting drug alisporivir and the acid sphingomyelinase-inactivating drug, desipramine, synergize to reverse susceptibility, suggesting the therapeutic potential of these orally active drugs against tuberculosis and possibly other TNF-mediated diseases.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Tuberculosis", "title": "Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Ulcer", "title": "Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Ureteral obstruction", "title": "The prominent accumulation of \u03b1-SMA+ myofibroblasts and interstitial collagen deposition seen in WT UUO was significantly reduced in CypD\u003csup\u003e-/-\u003c/sup\u003e UUO on day 12, but not day 7.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Acute pancreatitis", "title": "\u2022Pancreatitis-inducing factors open the membrane transition pore (mPTP) channel via cyclophilin D activation in acinar cells, causing calcium overload and cell death; genetic or pharmacological inhibition of mPTP improves the outcome of acute pancreatitis in animal models.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Alzheimer\u0027s Disease", "title": "In addition, in view of CypD and F1FO ATP synthase alterations seen in AD brains, the results further suggest that CypD-mediated F1FO ATP synthase deregulation is a\u00a0shared mechanism linking mitochondrial deficits in brain aging and AD.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Alzheimer\u0027s Disease", "title": "Several recent studies have found that CypD promotes the formation of the mPTP upon binding to \u03b2 amyloid (A\u03b2) peptides inside brain mitochondria, suggesting that neuronal CypD has a potential to be a promising therapeutic target for Alzheimer\u0027s disease (AD).", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Alzheimer\u0027s Disease", "title": "Moreover, the ablation of CypD also attenuates OSCP/A\u03b2 interaction in AD mice.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Alzheimer\u0027s Disease", "title": "These data demonstrate that abrogation of CypD results in persistent life-long protection against A\u03b2 toxicity in an Alzheimer\u0027s disease mouse model, thereby suggesting that blockade of CypD may be of benefit for Alzheimer disease treatment.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Alzheimer\u0027s Disease", "title": "We therefore set out to perform a proof of concept study to determine whether anesthesia and surgery can have different effects in male and female AD transgenic (Tg) mice, and in female AD Tg plus Cyclophilin D knockout (CypD KO) mice.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Alzheimer\u0027s Disease", "title": "It has been hypothesized that 17\u03b2-HSD10 interacts with cypD preventing it from opening mitochondrial permeability transition pores and that its regulation during AD may be affected by the accumulation of A\u03b2.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Amyloidosis", "title": "Several recent studies have found that CypD promotes the formation of the mPTP upon binding to \u03b2 amyloid (A\u03b2) peptides inside brain mitochondria, suggesting that neuronal CypD has a potential to be a promising therapeutic target for Alzheimer\u0027s disease (AD).", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Amyotrophic Lateral Sclerosis", "title": "In mice expressing three different ALS-causing SOD1 mutants, we now test the contribution of the loss of mitochondrial Ca(2+)-buffering capacity to disease mechanism(s) by eliminating ubiquitous expression of cyclophilin D, a critical regulator of Ca(2+)-mediated opening of the mitochondrial permeability transition pore that determines mitochondrial Ca(2+) content.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of breast", "title": "Coupling of low RRM2B and high CypD expression is associated with aggressive manifestations of breast cancer.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "The opening of the mitochondrial permeability transition pore (PTP), which is regulated by the matrix protein cyclophilin D (CypD), plays a key role in the pathophysiology of post-cardiac arrest (CA) syndrome.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "The mitochondrial pepdidyl-prolyl isomerase cyclophilin D (CypD) is an important regulator of the mitochondrial permeability transition and a key player in mitochondria physiology; however, its role in cancer is still unclear.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Renal fibrosis", "title": "Activation of several pro-fibrotic signalling pathways (p38 MAPK, JNK and Smad3) was unaltered in CypD\u003csup\u003e-/-\u003c/sup\u003e UUO, arguing that CypD acts independently to promote renal fibrosis.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Myocardial Ischemia", "title": "Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection?", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Adrenoleukodystrophy", "title": "Thus, cyclophilin D could serve as a therapeutic target for the treatment of X-ALD and cyclophilin D-dependent neurodegenerative and non-neurodegenerative diseases.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Mitochondrial Myopathies", "title": "Here we show that the Tfam KO mice have increased CypD levels, and we demonstrate that this increase is a common feature in patients with mitochondrial myopathy.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Tumor Progression", "title": "Using cellular and in vivo mouse models, we demonstrated that CypD protein upregulation induced by oncogenic Ras through the Raf-1/MEK/ERK pathway has a deterministic role in tumor progression.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Muscle degeneration", "title": "Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Pancreatic carcinoma", "title": "Gemcitabine-induced pancreatic cancer cell death is associated with MST1/cyclophilin D mitochondrial complexation.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of lung", "title": "Thus, cinobufotalin mainly induces Cyp-D-dependent non-apoptotic death in cultured lung cancer cells.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Adult Meningioma", "title": "We report that cyclophilin D levels were upregulated in all grades of human meningioma compared to control meninges.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Adult Glioblastoma", "title": "Significantly, we provide evidence that CYPD-mediated opening of the mPTP is required for gossypol-induced mitochondrial dysfunction, autophagy and cell death during organismic aging of P. anserina and in glioblastoma cells.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Childhood Glioblastoma", "title": "Significantly, we provide evidence that CYPD-mediated opening of the mPTP is required for gossypol-induced mitochondrial dysfunction, autophagy and cell death during organismic aging of P. anserina and in glioblastoma cells.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Impaired cognition", "title": "Hyperglycemia exacerbated the upregulation of CypD, mitochondrial defects, synaptic injury, and cognitive dysfunction in the brains of transgenic AD mice overexpressing amyloid-\u03b2 as shown by decreased mitochondrial respiratory complex I and IV enzyme activity and greatly decreased mitochondrial respiratory rate.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Impaired cognition", "title": "Regulation of Sirtuin 3-Mediated Deacetylation of Cyclophilin D Attenuated Cognitive Dysfunction Induced by Sepsis-Associated Encephalopathy in Mice.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Glaucoma, Primary Open Angle", "title": "There was increased [Ca(2+)](c), [Ca(2+)](m), mCICR, MPTP opening, and expression of cyclophilin D and decreased DeltaPsim in POAG TM cells compared with control cells.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Familial dilated cardiomyopathy", "title": "Since it is encoded by a gene located within this FDCM critical region, PPIF was considered a potential candidate gene for FDCM.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of pancreas", "title": "Gemcitabine-induced pancreatic cancer cell death is associated with MST1/cyclophilin D mitochondrial complexation.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Sepsis-Associated Encephalopathy", "title": "The levels of CypD and acetylation of CypD increased in the hippocampus induced by SAE.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Non-alcoholic Fatty Liver Disease", "title": "Its deficiency induces ER stress by suppressing Cyp-D ubiquitination, a key regulator of the mitochondrial Ca\u003csup\u003e2+\u003c/sup\u003e conductance channel mPTP, and results in hepatic steatosis. mGPDH may be a potential therapeutic target for the treatment of NAFLD.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Sleep Apnea, Central", "title": "Blockade of CypD by pharmaceutical inhibitor cyclosporine A (CsA) significantly protected against Dex-induced oxidative stress accumulation in gingival tissue.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Metabolic Syndrome X", "title": "Since obesity and metabolic syndrome decrease SIRT3 activity and expression, we tested the hypothesis that CypD hyperacetylation promotes mitochondrial dysfunction under this pathophysiological state, which is associated with ventricular dysfunction and heart failure.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neurodegenerative Disorders", "title": "Thus, cyclophilin D could serve as a therapeutic target for the treatment of X-ALD and cyclophilin D-dependent neurodegenerative and non-neurodegenerative diseases.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carcinogenesis", "title": "Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Breast Carcinoma", "title": "Coupling of low RRM2B and high CypD expression is associated with aggressive manifestations of breast cancer.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Breast Carcinoma", "title": "Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carcinoma of lung", "title": "Thus, cinobufotalin mainly induces Cyp-D-dependent non-apoptotic death in cultured lung cancer cells.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Colon Carcinoma", "title": "This study aims to assess the effects of GAD on the energy metabolism of colon cancer through the regulation of SIRT3 expression and whether this effect is related to acetylated cyclophilin D. The results demonstrated that GAD inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cockayne Syndrome, Type I", "title": "Blockade of CypD by pharmaceutical inhibitor cyclosporine A (CsA) significantly protected against Dex-induced oxidative stress accumulation in gingival tissue.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cardiomyopathies", "title": "Impaired NF-\u03baB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Ischemic stroke", "title": "Our study firstly identifies ERK-CypD axis is one of the cornerstones of the cell death pathways following ischemic stroke, and confirms GA is a novel inhibitor of MPTP, which inhibits apoptosis depending on regulating the ERK-CypD axis.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Ischemic stroke", "title": "Neutrophil depletion in wildtype mice conferred protection from ischemic stroke similarly to mice with CypD-deficient platelets.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "The mitochondrial pepdidyl-prolyl isomerase cyclophilin D (CypD) is an important regulator of the mitochondrial permeability transition and a key player in mitochondria physiology; however, its role in cancer is still unclear.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Mammary Neoplasms", "title": "Two genes (EEF1A2 and PPIF) could similarly separate ER+, TAM-treated breast tumors by DMFS, and their protein levels were measured in an ER+ breast cancer cell line model with exogenous ERR\u03b3.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Glioblastoma Multiforme", "title": "Significantly, we provide evidence that CYPD-mediated opening of the mPTP is required for gossypol-induced mitochondrial dysfunction, autophagy and cell death during organismic aging of P. anserina and in glioblastoma cells.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Meningioma, benign, no ICD-O subtype", "title": "We report that cyclophilin D levels were upregulated in all grades of human meningioma compared to control meninges.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Liver carcinoma", "title": "For CYP3 family, the expression of PXR was decreased 60% in HCC, together with decreases in CYP3A4, CYP3A5, and CYP3A7.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Steatohepatitis", "title": "Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Memory dysfunction", "title": "Activating SIRT3-mediated deacetylation of CypD attenuated learning and memory dysfunction induced by SAE.", "to": "CYP3"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Common Variable Immunodeficiency", "title": "Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Fever", "title": "Classical Swine Fever Virus p7 Protein Interacts with Host Protein CAMLG and Regulates Calcium Permeability at the Endoplasmic Reticulum.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "leukemia", "title": "Breast cancer cell lines were found to express CAML at higher levels than cell lines originating from leukemia and other cancers.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Leukemia, Myelocytic, Acute", "title": "Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Lymphoma", "title": "A proliferation-inducing ligand (APRIL), as well as its receptors transmembrane activator and calcium-modulating cyclophilin ligand (CAML) interactor (TACI) and B-cell maturation antigen (BCMA), has been shown to be important in B-cell biology, and overexpression of APRIL in mice results in development of lymphoma.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "melanoma", "title": "In this study, we demonstrate that the endoplasmic reticulum (ER)-associated protein calcium-modulating cyclophilin ligand (CAML) is bound to Basigin, a widely expressed integral plasma membrane glycoprotein and extracellular matrix metalloproteinase inducer (EMMPRIN, or CD147) implicated in melanoma proliferation, invasiveness, and metastasis.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasm Metastasis", "title": "In this study, we demonstrate that the endoplasmic reticulum (ER)-associated protein calcium-modulating cyclophilin ligand (CAML) is bound to Basigin, a widely expressed integral plasma membrane glycoprotein and extracellular matrix metalloproteinase inducer (EMMPRIN, or CD147) implicated in melanoma proliferation, invasiveness, and metastasis.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of breast", "title": "These results suggest a new role for CAML in breast cancer development.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Breast Carcinoma", "title": "These results suggest a new role for CAML in breast cancer development.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Adult Lymphoma", "title": "A proliferation-inducing ligand (APRIL), as well as its receptors transmembrane activator and calcium-modulating cyclophilin ligand (CAML) interactor (TACI) and B-cell maturation antigen (BCMA), has been shown to be important in B-cell biology, and overexpression of APRIL in mice results in development of lymphoma.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Childhood Leukemia", "title": "Breast cancer cell lines were found to express CAML at higher levels than cell lines originating from leukemia and other cancers.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Childhood Lymphoma", "title": "A proliferation-inducing ligand (APRIL), as well as its receptors transmembrane activator and calcium-modulating cyclophilin ligand (CAML) interactor (TACI) and B-cell maturation antigen (BCMA), has been shown to be important in B-cell biology, and overexpression of APRIL in mice results in development of lymphoma.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Acquired Hypogammaglobulinemia", "title": "Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.", "to": "GET2"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carcinoma", "title": "Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of endometrium", "title": "Down-regulation of focal adhesion signaling in response to cyclophilin A knockdown in human endometrial cancer cells, implicated by cDNA microarray analysis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of skin", "title": "Surgery combined with local 5-aminolevulinic acid-photodynamic therapy on skin cancer and its effect on the expression of cyclophilin A, cyclophilin B and CD147.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Non-Small Cell Lung Carcinoma", "title": "Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Non-Small Cell Lung Carcinoma", "title": "The present study aimed to examine 10 housekeeping genes (HKGs), including 18s ribosomal RNA (18S), glyceraldehyde\u20113\u2011phosphate dehydrogenase (GAPDH), ribosomal protein large P0 (RPLP0), \u03b2\u2011actin (ACTB), peptidylprolyl isomerase A (PPIA), phosphoglycerate kinase\u20111 (PGK1), \u03b2\u20112\u2011microglobulin (B2M), ribosomal protein LI3a (RPL13A), hypoxanthine phosphoribosyl transferase\u20111 (HPRT1) and TATA box binding protein (TBP) in order to identify the most stable and suitable reference genes for use in expression studies in non\u2011small cell lung cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Non-Small Cell Lung Carcinoma", "title": "Significantly, we show for the first time that CypA increased NSCLC cell invasion by regulating the activity of secreted matrix metallopeptidase 9 (MMP9).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Non-Small Cell Lung Carcinoma", "title": "Two hundred and thirty-four primary NSCLC specimens reflecting a broad range of histologies and stages were examined for CyPA and MIF reactivity by tissue microarray immunohistochemistry (TMA-IHC).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Non-Small Cell Lung Carcinoma", "title": "The p38 inhibitor SB203580 was used to show that p38 MAPK is involved in CypA-mediated NSCLC metastasis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Non-Small Cell Lung Carcinoma", "title": "Collectively, this study demonstrates that pharmacologic inhibition of CypA offers a potential therapeutic strategy via specific activation of p53-72R in NSCLC.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Squamous cell carcinoma", "title": "At least, SCC antigen, G protein, glutathione S-transferase, manganese superoxide dismutase, annexins, voltage-dependent anion channel, cyclophilin A, stratifin and galectin 7 are candidates for targeted proteins.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cardiovascular Diseases", "title": "Cyclophilin A (CypA) is secreted in response to oxidative stress and promotes inflammation and cardiovascular disease.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cardiovascular Diseases", "title": "The aim of this study was to investigate possible associations of CyPA platelet surface expression and a clinically relevant CyPA single-nucleotide polymorphism (CyPA PPIA rs6850) with prognosis in patients with symptomatic cardiovascular disease.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cardiovascular Diseases", "title": "Based on accumulating evidence, both CyPA and melatonin play important roles in cardiovascular diseases.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cardiovascular Diseases", "title": "This review discusses recently available data about CyPA in cardiovascular diseases, viral infections, neurodegeneration, cancer, rheumatoid arthritis, sepsis, asthma, periodontitis and aging.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cardiovascular Diseases", "title": "Additionally, plasma soluble Bsg levels are increased and predict all-cause death in patients with heart failure, suggesting that CyPA and Bsg are novel biomarkers for cardiovascular diseases.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cardiovascular Diseases", "title": "Cyclophilin A (CyPA) is involved in the pathophysiology of several inflammatory and cardiovascular diseases.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carotid Stenosis", "title": "Cyclophilin A: A Predictive Biomarker of Carotid Stenosis in Cerebral Ischemic Stroke.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carotid Stenosis", "title": "Cyclophilin A (CypA), secreted from vascular smooth muscle cells and inflammatory cells in response to oxidative stress, promotes vascular atherosclerosis and development of carotid stenosis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cerebral Infarction", "title": "Increased concentration of plasma CypA in acute cerebral infarction was demonstrated clinically.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant tumor of cervix", "title": "Annexin profiling suggested that cell death could be due to necrosis as observed by upregulation of necrotic markers such as LDH A, Rip-1, and Cyclophilin A. Necrosis appears to be a better therapeutic response as it could further activate pro-inflammatory cytokines to attract immune cells to eliminate HPV-integrated cells and therefore TALEN editing strategy has the potential to be a promising tool as an adjuvant therapy in cervical cancer along with surgery.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Colorectal Carcinoma", "title": "The pair PPIA/RPLP0 is a common optimal reference for studies encompassing tissues sampled from colorectal cancer and IBD patients.Using ACTB or B2M is not recommended.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary Arteriosclerosis", "title": "Moreover, plasma CyPA levels can predict all-cause death in patients with coronary artery disease and pulmonary hypertension.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary Arteriosclerosis", "title": "The results indicate that plasma CyPA levels can be used to predict all-cause death, rehospitalization, and coronary revascularization in patients with coronary artery disease and that when combined with other biomarkers (hsCRP and brain natriuretic peptide levels), the CyPA levels have further enhanced prognostic impacts in those patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary Arteriosclerosis", "title": "Platelet surface expression of cyclophilin A is associated with increased mortality in patients with symptomatic coronary artery disease.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary Arteriosclerosis", "title": "Platelet-bound cyclophilin A in patients with stable coronary artery disease and acute myocardial infarction.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary Arteriosclerosis", "title": "Welchs two-sample t test indicated an association of SNP rs6850: A\u00a0\u003e\u00a0G, located at the 5\u0027 UTR region with increased plasma levels of cyclophilin A in patients with coronary artery disease and with coronary artery disease associated with diabetes.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary heart disease", "title": "Moreover, plasma CyPA levels can predict all-cause death in patients with coronary artery disease and pulmonary hypertension.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary heart disease", "title": "Platelet-bound cyclophilin A in patients with stable coronary artery disease and acute myocardial infarction.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary heart disease", "title": "Welchs two-sample t test indicated an association of SNP rs6850: A\u00a0\u003e\u00a0G, located at the 5\u0027 UTR region with increased plasma levels of cyclophilin A in patients with coronary artery disease and with coronary artery disease associated with diabetes.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary heart disease", "title": "The results indicate that plasma CyPA levels can be used to predict all-cause death, rehospitalization, and coronary revascularization in patients with coronary artery disease and that when combined with other biomarkers (hsCRP and brain natriuretic peptide levels), the CyPA levels have further enhanced prognostic impacts in those patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary heart disease", "title": "Platelet surface expression of cyclophilin A is associated with increased mortality in patients with symptomatic coronary artery disease.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Dermatitis, Atopic", "title": "Furthermore, KLK7 (1.8-fold) and PPIA (0.65-fold) proteins were differentially expressed in lesional biopsy specimens from patients with AE relative to normal skin.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes", "title": "Cyclophilin A was also detected in the plasma of patients with diabetes.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes", "title": "Welchs two-sample t test indicated an association of SNP rs6850: A\u00a0\u003e\u00a0G, located at the 5\u0027 UTR region with increased plasma levels of cyclophilin A in patients with coronary artery disease and with coronary artery disease associated with diabetes.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes", "title": "The means by which cyclophilin A contributes to vascular lesion development in diabetes is however largely unknown.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes Mellitus", "title": "The means by which cyclophilin A contributes to vascular lesion development in diabetes is however largely unknown.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes Mellitus", "title": "Cyclophilin A was also detected in the plasma of patients with diabetes.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes Mellitus", "title": "Welchs two-sample t test indicated an association of SNP rs6850: A\u00a0\u003e\u00a0G, located at the 5\u0027 UTR region with increased plasma levels of cyclophilin A in patients with coronary artery disease and with coronary artery disease associated with diabetes.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes Mellitus, Non-Insulin-Dependent", "title": "The association of SNPs with known blood markers of type 2 diabetes and coronary artery disease such as HbA1c, low- and high-density lipoproteins, triglycerides, fasting and postprandial blood sugar levels, and cyclophilin A were probed.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes Mellitus, Non-Insulin-Dependent", "title": "Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetes Mellitus, Non-Insulin-Dependent", "title": "Diagnostic accuracy of both markers was determined for prediction of DN via receiver operating characteristic curve analyses.Urinary cyclophilin A and periostin levels were significantly higher in DN groups when compared with T2DM with normoalbuminuria group.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetic Angiopathies", "title": "Increasing clinical evidence supports a role for the secretory protein, cyclophilin A in diabetic vascular disease.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetic Nephropathy", "title": "Periostin exhibits a higher diagnostic accuracy than urinary cyclophilin A specifically in overt DN stage.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Diabetic Nephropathy", "title": "Cyclophilin A and CD147 associate with progression of diabetic nephropathy.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Dysmenorrhea", "title": "However, stromal and vascular endothelial CyPA expression were correlated with dysmenorrhea recurrence (p = 0.0023 and p = 0.0003, respectively).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Encephalomyelitis", "title": "These results showed that the loss of cyclophilin A results in altered peripheral immune activation and CNS leukocyte infiltration, but these changes did not result in a substantial change in the clinical course of EAE.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Endometrial Neoplasms", "title": "Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Endometrial Neoplasms", "title": "In conclusion, our results recommend the use of PPIA as a single reference gene to be considered for improved reliability of normalization in gene expression studies involving endometrial tumor samples at different tumor degrees.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Epilepsy", "title": "Uncaria rhynchophylla upregulates the expression of MIF and cyclophilin A in kainic acid-induced epilepsy rats: A proteomic analysis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Fibromuscular Dysplasia", "title": "To understand better the role of nonstructural protein 2B of the causative agent FMD virus (FMDV) in the process of virus replication, we identified a porcine host protein, cyclophilin A (CypA), which interacts with FMDV 2B.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Foot-and-Mouth Disease", "title": "Foot-and-mouth disease virus nonstructural protein 2B interacts with cyclophilin A, modulating virus replication.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Glioblastoma", "title": "After systemic administration of these new siRNA delivery NPs, they can target the glioma cells and efficiently inhibit the GBM tumor growth by silencing the expression of cyclophilin A (CypA), which is up-regulated in brain cancer and plays an important role in malignant transformation of brain cancer and maintaining glioma cell stemness.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Glioblastoma", "title": "These results not only establish the relevance of CypA to glioblastoma growth in vitro and in vivo, but also suggest that small interfering RNA-based CypA knockdown could be an effective therapeutic approach against glioblastomas.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Glioma", "title": "After systemic administration of these new siRNA delivery NPs, they can target the glioma cells and efficiently inhibit the GBM tumor growth by silencing the expression of cyclophilin A (CypA), which is up-regulated in brain cancer and plays an important role in malignant transformation of brain cancer and maintaining glioma cell stemness.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Glioma", "title": "Cyclophilin A Maintains Glioma-Initiating Cell Stemness by Regulating Wnt/\u03b2-Catenin Signaling.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hamartoma Syndrome, Multiple", "title": "This study analyzes the correlation between cyclophilin A, matrix metalloproteinase (MMP)-9, and tissue inhibitor of MMP (TIMP)/MMP-9 complexes in the inflamed and non-inflamed colon mucosa of UC and CD patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hay fever", "title": "Eight Ole e 15-PPIA chimeras were produced in E. coli, purified and tested with 20 sera from Ole e 15-sensitized patients with olive pollen allergy by ELISA experiments.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Heart failure", "title": "Importantly, plasma CyPA levels are increased in patients with coronary artery disease, abdominal aortic aneurysms, pulmonary hypertension, and heart failure.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Heart failure", "title": "Here, we review the potential roles of CyPA and CD147 in cardiac remodelling and their implications for the development of novel pharmacological therapies for heart failure.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Heart failure", "title": "The events triggered by CyPA cause a decline of diastolic and systolic function and finally lead to the occurrence of heart failure.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Congestive heart failure", "title": "The events triggered by CyPA cause a decline of diastolic and systolic function and finally lead to the occurrence of heart failure.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Congestive heart failure", "title": "Importantly, plasma CyPA levels are increased in patients with coronary artery disease, abdominal aortic aneurysms, pulmonary hypertension, and heart failure.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Congestive heart failure", "title": "Here, we review the potential roles of CyPA and CD147 in cardiac remodelling and their implications for the development of novel pharmacological therapies for heart failure.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis B", "title": "Proteomic analysis of hepatitis B surface antigen positive transgenic mouse liver and decrease of cyclophilin A.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis B", "title": "A number of reports have demonstrated that CyPA plays a critical role in the successful replication of viruses such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), etc.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis C", "title": "Interestingly, the hepatitis C virus (HCV) non-structural 5A (NS5A) protein, which is known to modulate the IFN response, competes with IRF9 for CypA binding and can prevent the formation of IRF9-CypA complexes.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis C", "title": "Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis C", "title": "A number of reports have demonstrated that CyPA plays a critical role in the successful replication of viruses such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), etc.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis C", "title": "We thus compared the ability of CypA from mouse, tree shrew, and seven non-human primate species to support HCV replication, finding that murine CypA only partially rescued viral replication in Huh7.5-shRNA CypA cells.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis C", "title": "Engineering the mutations into wild-type HCV fully recapitulated the CyPA-independent and CsA-resistant phenotype and four putative proline substrates of CyPA were mapped to the vicinity of the DY motif.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis C", "title": "We also investigated the effect of D2 mutations conferring resistance of HCV replication to cyclophilin A (CypA) inhibitors on the structure of the recombinant D2 Con1 mutants and their binding to CypA.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis C", "title": "They include second-wave, first-generation, and second-generation NS3-4A protease inhibitors, nucleoside/nucleotide analogue inhibitors, and non-nucleoside inhibitors of HCV RNA-dependent RNA polymerase, inhibitors of nonstructural protein 5A and host-targeted agents, such as cyclophilin A inhibitors and microRNA-122 antagonists.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis C", "title": "Using shRNAs, we showed that CypA was required for replication of HCV in Huh-7.5 cells and identified 3 SNPs in PPIA that protected cells from HCV entry or replication.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis C", "title": "No direct molecular interaction has been detected by NMR spectroscopy between HCV NS5B(\u039421) and host CypA.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis C", "title": "Interactions of the Disordered Domain II of Hepatitis C Virus NS5A with Cyclophilin A, NS5B, and Viral RNA Show Extensive Overlap.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis C", "title": "Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis C", "title": "Our data further show that MxB interacts with the HCV protein NS5A, thereby impairing NS5A interaction with CypA and NS5A localization to the endoplasmic reticulum, two events essential for HCV RNA replication.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Herpesviridae Infections", "title": "The stability of PPIA is in line with other studies investigating different herpesvirus infections whereas the finding that HHV-6B significantly upregulates TBP is novel and most likely specific to HHV-6B.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "HIV Infections", "title": "However, we find that CypA is not required for the decreased infection observed in SUN2-silenced cells and, conversely, that endogenous SUN2 is not required for the well-documented positive modulation of HIV infection by CypA.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hypercholesterolemia", "title": "The analysis of classical risk factors for atherosclerosis revealed that patients with hypertension and hypercholesterolemia had significantly enhanced platelet-bound CyPA, whereas diabetes and smoking were not associated with enhanced CyPA-binding to the platelet surface.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hypercholesterolemia", "title": "Enhanced CyPA platelet surface expression is associated with hypertension and hypercholesterolemia in patients with stable coronary artery disease (CAD).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hypercholesterolemia", "title": "In the present study, we tested the hypothesis that CAV-1 improves dyslipidemia, inhibits cyclophilin A (CypA)- mediated ROS production, prevents mitochondrial compensatory action and attenuates oxidative stress responses in cholesterol-induced hypercholesterolemia.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hyperglycemia", "title": "Our findings confirm that HPRT1, GUSB and PPIA are the most suitable reference genes for RPE cell gene expression experiments subjected to hypoxia and/or hyperglycemia.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hypertensive disease", "title": "Serum CyPA levels and the expression kinetics of CyPA\u2011associated signaling pathways were examined following simvastatin treatment in rat thoracic aortas during hypertension.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hypertensive disease", "title": "Enhanced CyPA platelet surface expression is associated with hypertension and hypercholesterolemia in patients with stable coronary artery disease (CAD).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hypertensive disease", "title": "Moreover, plasma CyPA levels can predict all-cause death in patients with coronary artery disease and pulmonary hypertension.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hypertensive disease", "title": "Among the risk factors for cerebral stroke examined in this study, only hypertension was significantly associated with plasma Cyclophilin A level.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hypertensive disease", "title": "Enhanced platelet-bound CyPA is associated with hypertension and hypercholesterolemia in stable CAD patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Inflammatory Bowel Diseases", "title": "However, further studies are necessary to verify the role of CyPA in IBD development.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Influenza", "title": "This review briefly summarizes recent advances in understanding the roles of CypA during influenza virus infection.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Influenza", "title": "ChCypA protein was shown to be able to specifically interact with influenza virus M1 protein.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Kidney Diseases", "title": "Albuminuria is the currently accepted marker for detection of DN.This study aims to evaluate the urinary level of two novel renal tubular proteins (cyclophilin A and periostin) in patients with T2DM and among different nephropathy stages and also to validate the diagnostic accuracy of both cyclophilin A and periostin as potential markers for early prediction of DN relative to albuminuria.This cross-sectional study recruited 137\u2009patients with T2DM, and they were divided based on their urinary albumin:creatinine ratio into T2DM with normoalbuminuria (\u003ci\u003egroup II\u003c/i\u003e), incipient T2DN with microalbuminuria (\u003ci\u003egroup III\u003c/i\u003e) and overt T2DN with macroalbuminuria (\u003ci\u003egroup\u003c/i\u003e\u003ci\u003eIV\u003c/i\u003e) beside 41 healthy subjects as \u003ci\u003egroup I\u003c/i\u003e Cyclophilin A and periostin were measured in the urine using ELISA.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Acute Megakaryocytic Leukemias", "title": "We determined the expression of alphaSMA and megakaryoblastic leukemia-1 (MKL1), a transcriptional regulator of alphaSMA, by quantitative real-time PCR using three common internal controls, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), cyclophilin A and 18S rRNA.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Leukemia, Myelocytic, Acute", "title": "High expression levels of PPIA were associated with decreased overall survival in low grade glioma, acute myeloid leukemia, lung adenocarcinoma, skin cutaneous melanoma and liver hepatocellular carcinoma (LIHC).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Listeriosis", "title": "Our results demonstrate a crucial role for CypA during Listeria infections.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Chronic Obstructive Airway Disease", "title": "Serum CyPA positively correlated with serum interleukin-6, matrix metalloproteinase-9 and high-sensitivity C-reactive protein in both the exacerbation and convalescence phases of COPD.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Lung Neoplasms", "title": "Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Lung Neoplasms", "title": "Two differentially expressed protein peaks at m/z 12338 and 17882 in the MALDI-TOF spectra were identified in lung tumor specimens as macrophage migration inhibitory factor and cyclophilin A, respectively.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Lupus Erythematosus, Systemic", "title": "Autoantibodies against cyclophilin, a cyclosporin A binding protein, were detected in sera of 29 of 46 (63%) patients with systemic lupus erythematosus and 14 of 40 (35%) Lyme disease patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Lymphoma", "title": "Loss of expression of B2M, and gain of expression of PRDX1 and PPIA was confirmed in the cell lines and primary lymphoma tissue.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of stomach", "title": "Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of stomach", "title": "Transient suppression of CypA reduced the proliferation of BGC-823 and SGC-7901 GC cell lines.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "melanoma", "title": "High expression levels of PPIA were associated with decreased overall survival in low grade glioma, acute myeloid leukemia, lung adenocarcinoma, skin cutaneous melanoma and liver hepatocellular carcinoma (LIHC).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Mouth Neoplasms", "title": "Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Mycoplasma Infections", "title": "Cyclophilin A is the potential receptor of the Mycoplasma genitalium adhesion protein.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Myocardial Infarction", "title": "We hypothesized that the genetic variation at the cyclophilin A gene (PPIA) could affect the risk for developing atherosclerosis and myocardial infarction.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Myocardial Infarction", "title": "The CyPA platelet surface expression is associated with mortality whereas CyPA PPIA rs6850 is associated with recurrent MI in patients with symptomatic CAD.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasm Metastasis", "title": "Cyclophilin A-EMMPRIN interaction induces invasion of head and neck             squamous cell carcinoma.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasm Metastasis", "title": "The suppression of CypA expression was correlated with decreased NSCLC cell tumorigenesis and metastasis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasm Metastasis", "title": "Twenty-one genes related to metastasis were altered by CypA over-expression.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasm Metastasis", "title": "Further, CYPA was significantly associated with clinical stage and lymphnode metastasis of SOC patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasm Metastasis", "title": "Overexpression of CypA and metastasis were significantly associated with shorter progression free survival times in univariate analysis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasm Metastasis", "title": "Lung metastasis mouse models were used for the first time to confirm that CypA promoted NSCLC metastasis in vivo.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "A novel synergy of anti-GM3 antibody and cyclophilin A inhibitor was found to mimic the very low pHe-mediated GM3 supraclustered conformation that elevated the surface rigidity and mechano-remodeled the tumor cell into a differentiated phenotype which eventually succumbed to the anoikis type of cell death, thereby eradicating the tumorigenic niches.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "Knockdown of cyclophilin A expression by RNA interference led to the significant suppression of the cell growth and the induction of apoptosis in endometrial carcinoma HEC-1-B cells in vitro (p \u003c 0.01) and the inhibition of tumor growth in vivo (p \u003c 0.01).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "In this study, we investigate the functions of CypA and its mechanism of action in GICs\u0027 development.\u003cb\u003eExperimental Design:\u003c/b\u003e We analyzed differences in CypA expression between primary tumors and neurospheres from the GDS database, both before and after GIC differentiation.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "Suppression of CypA expression decreases proliferation of CCA cell lines in vitro and reduces tumor growth in the nude mouse model.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "As the stable expression of HPRT1 and PPIA between normal and tumor endometrial samples fulfill the basic requirement of a reference gene to be used for normalization purposes, HPRT1 expression showed significant differences between samples from low-grade and high-grade tumors.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "Furthermore, a literature review shows that Heat shock protein 10 (Hsp10), single-stranded DNA-binding protein (SSBP1), and peptidyl-prolyl cis-trans isomerase A (PPIA), which were identified as being increased in the tumor samples in this study, may be closely related to protein folding and translation.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "An elevated expression of CypA in GC tissues compared with normal gastric mucosa was observed, especially in TNM stage-I and intestinal type of tumor.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "Surprisingly, HL001 selectively suppresses tumor growth in p53 wild-type NSCLC harboring Arg72 homozygous alleles (p53-72R) through disrupting interaction between MDM2 and p53-72R in a CypA-dependent manner.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "The prognostic effect of PPIA expression in LIHC was independent of tumor grade.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "Significant correlations were only found in high level of CypA and MMP9 expression with tumor differentiation and lymph node status.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "In this study, we showed that both HIF-1\u03b1 and CypA expression were significantly associated with lymph node metastasis and tumor stage.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "Recently, correlations of CypA with tumor pathogenesis have been studied.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "Moreover, PPIA expression was significantly associated with tumor size in these tissues.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neoplasms", "title": "The overall analysis obtained by the comprehensive ranking showed that RPS18 and PPIA are appropriate internal reference genes for tumor neovascularization studies where it is necessary to analyze both systems at the same time.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Obesity", "title": "The roles of PPIA in obesity were observed on a high-fat diet obesity model and a gestational diabetes obesity model.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Oral Submucous Fibrosis", "title": "Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Oral Submucous Fibrosis", "title": "From the proteomic analysis, 94 of the 182 selected spots with differential expression were identified by MS analysis and Cyclophilin A (CYPA) was determined to be the OSF-associated protein candidate.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Parasitic Diseases", "title": "PPIA can identify the patient with active recurrent OT from acute OT, other forms of uveitis and other parasitic infections.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Periodontitis", "title": "This study is to observe the expression and distribution of CyPA and CD68\u003csup\u003e+\u003c/sup\u003e cells in the histopathogenesis of rat ligation-induced experimental periodontitis, and assess the role of CyPA in CD68\u003csup\u003e+\u003c/sup\u003e cell infiltration in rat experimental periodontitis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Conventional (Clear Cell) Renal Cell Carcinoma", "title": "These data suggest that CypA may serve as a novel prognostic factor for ccRCC.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Schistosomiasis", "title": "The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Schizophrenia", "title": "The results show that people with schizophrenia had significantly less PPIA and SDHA mRNA and tended to have less GUSB and B2M mRNA, suggesting that these control genes may not be good candidates for normalization.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Septicemia", "title": "In this study, we explored whether CsCyPA immunization could prevent or ameliorate mice sepsis induced by cecum ligation puncture (CLP).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Smoking", "title": "Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Stomach Neoplasms", "title": "Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cerebrovascular accident", "title": "Our study revealed higher circulating serum levels of CypA in the hypertensive stroke group than in the non-hypertensive stroke group.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cerebrovascular accident", "title": "Increasted serum cyclophilin A concentrations are highly associated with stroke severity and prognosis after hemorrhagic stroke.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Ocular Toxoplasmosis", "title": "A validated PPIA assay may have a role in the diagnosis of the atypical OT patient before more invasive anterior chamber or vitreous tap is performed for PCR analysis or for Goldmann-Witner coefficient calculations.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Tuberculosis", "title": "Earlier, in our immunoproteomic analysis, we found that peptidyl-prolyl cis-trans isomerase A (PpiA) protein-containing fractions induced significantly higher interferon-gamma (IFN-\u03b3) response in LTBI than in PTB.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Uveitis", "title": "PPIA can identify the patient with active recurrent OT from acute OT, other forms of uveitis and other parasitic infections.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Vascular Diseases", "title": "Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Vascular Diseases", "title": "We examined the effect of single-nucleotide polymorphisms (SNPs) within the PPIA gene on plasma levels of cyclophilin A and coupled this with status of vascular disease in patients with and without type 2 diabetes in 212 South Indian subjects.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Vascular Diseases", "title": "Cyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitus.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Virus Diseases", "title": "Several coding and non-coding genetic variants in the PPIA gene encoding for CypA have been described, but there is only limited information about their influence on the course of viral infection.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Virus Diseases", "title": "It has been reported that human cellular cyclophilin A (CypA) impaired influenza virus infection in 293T cells.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Virus Diseases", "title": "Together, these evidences showed diverse roles of CyPA in viral infection.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Virus Diseases", "title": "This review briefly summarizes recent advances in understanding the roles of CypA during influenza virus infection.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Acute pancreatitis", "title": "Serum CypA concentrations were significantly lower in controls than in AP group.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Non-Small Cell Lung Carcinoma", "title": "Proteomic analysis of secreted proteins of non-small cell lung cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Alopecia", "title": "The molecular chaperone CypA stimulates hair follicle and HDP cells through Wnt/\u03b2-catenin signaling pathway, suggesting that it might be a key molecule for hair loss disorder therapy.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Alzheimer\u0027s Disease", "title": "The CD147 protein interacts with other proteins such as cyclophilin A (CyPA), Cyclophilin B (CyPB), sterol carrier protein (SCP), caveolin-1 and integrins, and can influence amyloid-\u03b2 (A\u03b2) peptide levels, a protein that is central to Alzheimer\u0027s disease (AD) pathogenesis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Alzheimer\u0027s Disease", "title": "Subsequently, using PPIA and UBE2D2 as ERGs for normalization, the mRNA levels of paraoxonase 1 (PON1) and paraoxonase 2 (PON2) were quantified in the frontal cortex of AD and control cases (n=80) and analyzed using the REST 2009 program.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Amyotrophic Lateral Sclerosis", "title": "Therefore, in the present study, we investigated the process of motor neuron degeneration as the disease progresses and to determine whether the CypA-AIF complex would play a role in inducing motor neuronal cell death in mutant superoxide dismutase 1 (SOD1)(G93A) ALS model mice.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Amyotrophic Lateral Sclerosis", "title": "Our results indicates that extracellular PPIA is a promising druggable target for ALS and support further studies to develop a therapy to arrest or slow the progression of the disease in patients.\u003cb\u003eSIGNIFICANCE STATEMENT\u003c/b\u003e We provide evidence that extracellular cyclophilin A, also known as peptidylprolyl cis-/trans-isomerase A (PPIA), is a mediator of the neuroinflammatory reaction in amyotrophic lateral sclerosis (ALS) and is toxic for motor neurons.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Arteriosclerosis", "title": "The analysis of classical risk factors for atherosclerosis revealed that patients with hypertension and hypercholesterolemia had significantly enhanced platelet-bound CyPA, whereas diabetes and smoking were not associated with enhanced CyPA-binding to the platelet surface.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Arteriosclerosis", "title": "Our data indicate that CyPA has proinflammatory effects on EC and may play an important role in the pathogenesis of inflammatory diseases, such as atherosclerosis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Arteriosclerosis", "title": "Cyclophilin A plays a pathogenic role in the development and progression of atherosclerosis, which can be assessed by measuring carotid intima-media thickness.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Arteriosclerosis", "title": "We hypothesized that the genetic variation at the cyclophilin A gene (PPIA) could affect the risk for developing atherosclerosis and myocardial infarction.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Arteriosclerosis", "title": "Using immunohistochemistry, we showed that REG\u03b3 was highly expressed in these plaques, and the result of RNA-seq in Human umbilical vein endothelial cells (HUVECs), led us to explore and indentify that REG\u03b3 significantly promoted cyclophilin A (CyPA) expression, which is a proinflammatory and proapoptotic molecule in atherosclerosis progression.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Arteriosclerosis", "title": "Growing evidence implicates cyclophilin A secreted by vascular wall cells and monocytes as a key mediator in atherosclerosis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Arteriosclerosis", "title": "Given the paracrine and autocrine actions of cyclophilin A, the secreted immunophilin could be significant for progression of atherosclerosis in type 2 diabetes.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Arteriosclerosis", "title": "Cyclophilin A (CypA), secreted from vascular smooth muscle cells and inflammatory cells in response to oxidative stress, promotes vascular atherosclerosis and development of carotid stenosis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Arteriosclerosis", "title": "Cyclophilin A (CyPA) is a major ROS-induced factor in atherosclerosis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Rheumatoid Arthritis", "title": "Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Rheumatoid Arthritis", "title": "Contribution of cyclophilin A to the regulation of inflammatory processes in rheumatoid arthritis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Rheumatoid Arthritis", "title": "Our study demonstrates that the increased expression of CD147 on neutrophils in RA may be responsible for CyPA-mediated neutrophil migration into the joints, elevated MMPs secretion and cell invasion of synoviocytes, all of which may contribute to the cartilage invasion and bone destruction of RA.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Asthma", "title": "The suitability of using the PPIA gene as the HKG for such studies was questioned due to its low expression in asthmatics.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Atherosclerosis", "title": "Pure, active, and uncontaminated CyPA does not induce endothelial TF or VCAM-1 expression; instead, it acts as a potent monocyte chemoattractant and induces monocyte Il-6 release, implying a role for extracellular CyPA in the pathogenesis of atherosclerosis via activation of monocytes rather than endothelial cells.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Atherosclerosis", "title": "Growing evidence implicates cyclophilin A secreted by vascular wall cells and monocytes as a key mediator in atherosclerosis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Atherosclerosis", "title": "Given the paracrine and autocrine actions of cyclophilin A, the secreted immunophilin could be significant for progression of atherosclerosis in type 2 diabetes.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Atherosclerosis", "title": "We hypothesized that the genetic variation at the cyclophilin A gene (PPIA) could affect the risk for developing atherosclerosis and myocardial infarction.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Atherosclerosis", "title": "Cyclophilin A (CypA), secreted from vascular smooth muscle cells and inflammatory cells in response to oxidative stress, promotes vascular atherosclerosis and development of carotid stenosis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Atherosclerosis", "title": "Using immunohistochemistry, we showed that REG\u03b3 was highly expressed in these plaques, and the result of RNA-seq in Human umbilical vein endothelial cells (HUVECs), led us to explore and indentify that REG\u03b3 significantly promoted cyclophilin A (CyPA) expression, which is a proinflammatory and proapoptotic molecule in atherosclerosis progression.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Atherosclerosis", "title": "The analysis of classical risk factors for atherosclerosis revealed that patients with hypertension and hypercholesterolemia had significantly enhanced platelet-bound CyPA, whereas diabetes and smoking were not associated with enhanced CyPA-binding to the platelet surface.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Atherosclerosis", "title": "Cyclophilin A plays a pathogenic role in the development and progression of atherosclerosis, which can be assessed by measuring carotid intima-media thickness.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Atherosclerosis", "title": "Cyclophilin A (CyPA) is a major ROS-induced factor in atherosclerosis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Atherosclerosis", "title": "Our data indicate that CyPA has proinflammatory effects on EC and may play an important role in the pathogenesis of inflammatory diseases, such as atherosclerosis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Bacterial Infections", "title": "Our findings further establish CypA as a component of dynamic actin-rich structures formed during bacterial infections and within cells in general.Anat Rec, 301:2086-2094, 2018.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Brain Neoplasms", "title": "After systemic administration of these new siRNA delivery NPs, they can target the glioma cells and efficiently inhibit the GBM tumor growth by silencing the expression of cyclophilin A (CypA), which is up-regulated in brain cancer and plays an important role in malignant transformation of brain cancer and maintaining glioma cell stemness.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of breast", "title": "Cyclophilin A (CypA) and ribosomal protein L17 (RPL17) were overexpressed in breast cancer-associated brain metastases, whereas tumor protein 63 (TP63) and von Willebrand factor A domain-containing 8 (VWA8) were significantly downregulated in breast cancer brain metastases.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of breast", "title": "We report that the peptidyl-prolyl isomerase (PPI) cyclophilin A (CypA), which is implicated in the regulation of protein conformation, is necessary for the prolactin (PRL)-induced activation of Jak2 and the progression of human breast cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of breast", "title": "Luciferase assay validated that PPIA was a direct target of miR-192-5p. miR-192-5p sensitizes breast cancer cells to DOX by targeting PPIA, suggesting that miR-192-5p might serve as a novel target for reversing DOX resistance and controlling breast tumor growth.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of breast", "title": "The prolyl isomerase cyclophilin A (CypA) regulates the Jak2/Stat5 pathway, which is necessary for mammary differentiation and the pathogenesis of breast cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of breast", "title": "Using MDA-MB-231 as a model breast cancer cell line, we provide evidence that PFN1 overexpression is associated with alterations in the expression of proteins that have been functionally linked to cell proliferation (FKPB1A, HDGF, MIF, PRDX1, TXNRD1, LGALS1, STMN1, LASP1, S100A11, S100A6), survival (HSPE1, HSPB1, HSPD1, HSPA5 and PPIA, YWHAZ, CFL1, NME1) and motility (CFL1, CORO1B, PFN2, PLS3, FLNA, FLNB, NME2, ARHGDIB).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "Due to its promotive effects on GICs, CypA is a potential target for future glioma therapy.\u003ci\u003e\u003c/i\u003e.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "We apply our approach to elucidate the allosteric mechanism in cyclophilin A (CypA), a peptidyl-prolyl cis-trans isomerase known to participate in diverse biological processes and be associated with many diseases including cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "Although overexpression of cyclophilin A (CypA) is associated with several types of cancer, its role in pancreatic cancer has not been studied.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "Many studies have provided compelling evidence supporting critical roles of CyPA in immune and infectious diseases and malignant tumours.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "In response to tumor hypoxia, cyclophilin A (CypA) is over-expressed in various cancer types, and is associated with cell apoptosis, tumor invasion, metastasis, and chemoresistance in PDAC.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "The expression level of PPIA was significantly associated with levels of basigin and signal transducer and activator of transcription 3, which may be major effectors of PPIA in the progression of the cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "CYPA has been implicated in several pathological processes, including cancer, inflammatory diseases, and HIV-1 infection.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "For example, CypA protein displays an unusually high expression in several cancer types and correlates with poor outcome of the patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "In this study, A549 and H1299 cell lines with downregulated and overexpressed CypA, respectively, were constructed by lentivirus transfection of NSCLC cells. in vitro experiments, including wound healing and transwell assays and Western blotting, showed that CypA promoted cancer cell migration and epithelial-mesenchymal transition in NSCLC.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "These results demonstrate an important role for CypA in the regulation of Jak2/Stat5-mediated biology in mammary epithelium, identifying this isomerase as a novel target for therapeutic intervention.\u003cb\u003eSignificance:\u003c/b\u003e These findings reveal cyclophilin A functions in normal mammary epithelial development and ErbB2-driven mammary tumorigenesis and suggest therapies targeting cyclophilin A may be efficacious for breast cancer treatment.\u003cb\u003eGraphical Abstract:\u003c/b\u003e http://cancerres.aacrjournals.org/content/canres/78/14/3877/F1.large.jpg \u003ci\u003e\u003c/i\u003e.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant Neoplasms", "title": "Although the interaction between cyclophilin A and CD147 is well established in inflammatory disease, that of cyclophilin B (CypB) with CD147 has not been fully explored, especially in cancer cell biology, and the exact molecular mechanism underlying such an association is poorly understood.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Gestational Diabetes", "title": "Serum CyPA and body mass index were independently associated with the development of complicated pregnancy as pre-eclampsia, GH or GDM.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Gestational Diabetes", "title": "The roles of PPIA in obesity were observed on a high-fat diet obesity model and a gestational diabetes obesity model.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hepatitis E", "title": "We further modified this line to rescue expression of CYPA before terminal differentiation to HLCs and performed HEV infection studies.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Left Ventricular Hypertrophy", "title": "High CyPA levels and low melatonin levels are independent risk factors for LVH (p\u00a0=\u00a00.000).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Small cell carcinoma of lung", "title": "Elucidation of the precise role of CypA in these pathways may lead to new targeted therapies for small cell lung cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Active tuberculosis", "title": "Earlier, in our immunoproteomic analysis, we found that peptidyl-prolyl cis-trans isomerase A (PpiA) protein-containing fractions induced significantly higher interferon-gamma (IFN-\u03b3) response in LTBI than in PTB.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cutaneous Melanoma", "title": "High expression levels of PPIA were associated with decreased overall survival in low grade glioma, acute myeloid leukemia, lung adenocarcinoma, skin cutaneous melanoma and liver hepatocellular carcinoma (LIHC).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Adenocarcinoma of lung (disorder)", "title": "Here we investigated the implications of CypA expression for outcome in patients with lung adenocarcinoma.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of mouth", "title": "Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of brain", "title": "After systemic administration of these new siRNA delivery NPs, they can target the glioma cells and efficiently inhibit the GBM tumor growth by silencing the expression of cyclophilin A (CypA), which is up-regulated in brain cancer and plays an important role in malignant transformation of brain cancer and maintaining glioma cell stemness.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Secondary malignant neoplasm of lung", "title": "Lung metastasis mouse models were used for the first time to confirm that CypA promoted NSCLC metastasis in vivo.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Acute myocardial infarction", "title": "In patients with acute myocardial infarction CyPA platelet surface expression is significantly decreased.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Acute myocardial infarction", "title": "Interestingly, in patients with acute myocardial infarction (AMI) platelet-bound CyPA was significantly decreased compared with patients with stable CAD.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Prion Diseases", "title": "This suggests that CypA contributes to dampening the pro-inflammatory microglial response during the early stage of RML-induced prion disease.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Right Ventricular Hypertrophy", "title": "In contrast, CyPA(\u00b1) and Bsg(\u00b1) mice exposed to hypoxia for 4 weeks revealed significantly reduced right ventricular systolic pressure, pulmonary artery remodeling, and right ventricular hypertrophy compared with their littermate controls.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Aortic Aneurysm, Abdominal", "title": "The AAA wall tissue from simvastatin-treated patients had significantly lower CyPA gene expression and protein levels (P = 0.0018, P = 0.0083, respectively).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Inflammatory disease of the central nervous system", "title": "The contribution of cyclophilin A to immune-mediated central nervous system inflammation.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cerebral Hypoxia-Ischemia", "title": "The Cyclophilin A (CypA)/Apoptosis Inducing Factor (AIF) complex is implicated in the DNA degradation in response to various cellular stress conditions, such as oxidative stress, cerebral hypoxia-ischemia and traumatic brain injury.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Tumor Progression", "title": "The mechanism by which CypA contributes to cancer progression appears to involve a complex interplay of proteins and pathways including membrane receptor for CypA, CD147, and CypA binding partners inside the cells.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Tumor Progression", "title": "Recently, various of studies indicated that CYPA has critical impact on cancer progression.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cholangiocarcinoma", "title": "However, the role and mechanisms of CypA in liver fluke-associated cholangiocarcinoma (CCA) are not presently known.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cholangiocarcinoma", "title": "Cyclophilin A (CypA) was shown to be upregulated in human cholangiocarcinoma (CCA) tissues.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Metastatic malignant neoplasm to brain", "title": "Furthermore, the expression of CypA and RPL17 in brain metastases were significantly increased compared with that in primary breast tumors, and the expression of TP63 and VWA8 in brain metastases were significantly decreased.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Congenital contractural arachnodactyly", "title": "Cell proliferation, cell cycle, ERK1/2, p38 MAPK, NF-\u03baB,\u00a0and STAT3 activities were examined by MTS assay, flow cytometry, and Western blot. sCypA was detected in CM from MMNK1 (an immortalized human cholangiocyte cell line) and six CCA cell lines.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Congenital contractural arachnodactyly", "title": "The effect of silencing CypA on CCA tumor growth was determined in nude mice.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Arthritis aggravated", "title": "Our findings provide evidence that PPIase CypA promoted macrophages polarization toward pro-inflammatory M1 phenotype via transcriptional activating NF-\u03baB, thus leading to aggravated arthritis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Pancreatic carcinoma", "title": "In this study the expression of CypA and its receptor CD147 on pancreatic cancer was determined as well as the effect of exogenous CypA on pancreatic cancer cell proliferation.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Pancreatic carcinoma", "title": "Thus, soluble CypA may affect cell growth of pancreatic cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Muscular Dystrophy, Facioscapulohumeral", "title": "To understand better the role of nonstructural protein 2B of the causative agent FMD virus (FMDV) in the process of virus replication, we identified a porcine host protein, cyclophilin A (CypA), which interacts with FMDV 2B.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Dyslipidemias", "title": "AP-CAV-1 enhanced CAV-1 expression by \u02c315%, inhibited CypA expression by \u02c350% (P \u003c 0.05) and significantly improved dyslipidemia, thus reducing neutral lipid peroxidation.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of lung", "title": "Cyclophilin A (CypA) is associated with metastasis in diverse cancers; however, its role in lung cancer metastasis and the underlying mechanisms remain poorly understood.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of lung", "title": "The current study focused on evaluating the potential of CyPA and MIF as prognostic markers in patients with a new diagnosis of lung cancer for rapid translation into clinical practice.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of lung", "title": "Here, we studied the expression of CypA and its receptor CD147 in several kinds of lung cancer cells as well as a normal lung cell and found that in H446 cell, a kind of small cell lung cancer cell, the expression are the highest.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Systemic Inflammatory Response Syndrome", "title": "Extracellular CyPA plays a prominent role in the pathological processes of inflammatory diseases, acting as a proinflammatory mediator, exerting chemotactic effects, promoting apoptosis of endothelial cells and amplifying ROS generation, thus being considered as a potential treatment target of sepsis, a systemic inflammatory response syndrome.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Sepsis", "title": "In this study, we explored whether CsCyPA immunization could prevent or ameliorate mice sepsis induced by cecum ligation puncture (CLP).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Dilatation of aorta", "title": "The expression analysis of these 32 genes by RT-qPCR showed that EIF2B1, ELF1, and PPIA remained constant in their expression levels in the different specimen groups, thus being insensitive to aortic valve morphology, aortic dilatation, hypertension, and medication with ACE inhibitors or AT1 receptor antagonists.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Endometrioma", "title": "Finally, the relationship between CyPA immunoreactivity and the clinicopathological findings related to endometrioma were evaluated.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Adult Glioblastoma", "title": "These results not only establish the relevance of CypA to glioblastoma growth in vitro and in vivo, but also suggest that small interfering RNA-based CypA knockdown could be an effective therapeutic approach against glioblastomas.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Adult Glioblastoma", "title": "Tumor-Associated Fibronectin Targeted Liposomal Nanoplatform for Cyclophilin A siRNA Delivery and Targeted Malignant Glioblastoma Therapy.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Squamous cell carcinoma of esophagus", "title": "This study analyzed the correlation of cyclophilin A (CypA) and matrix metalloproteinase 9 (MMP9) in ESCC and their relationships to clinicopathological features and survival.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Conventional (Clear Cell) Renal Cell Carcinoma", "title": "Our study demonstrated the suitability of the two housekeeping genes PPIA and TBP as endogenous reference genes when comparing malignant tissue samples with adjacent normal tissue samples from clear cell renal cell carcinoma.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Solid Neoplasm", "title": "Cyclophilin A (CypA) has been reported to be overexpressed in cancer cells, especially in solid tumors.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Solid Neoplasm", "title": "Although cyclophilin A (CypA) has been reported to be over-expressed in cancer cells and solid tumors, its expression and role in glioblastomas have not been studied.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Childhood Glioblastoma", "title": "Tumor-Associated Fibronectin Targeted Liposomal Nanoplatform for Cyclophilin A siRNA Delivery and Targeted Malignant Glioblastoma Therapy.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Childhood Glioblastoma", "title": "These results not only establish the relevance of CypA to glioblastoma growth in vitro and in vivo, but also suggest that small interfering RNA-based CypA knockdown could be an effective therapeutic approach against glioblastomas.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cervix carcinoma", "title": "Annexin profiling suggested that cell death could be due to necrosis as observed by upregulation of necrotic markers such as LDH A, Rip-1, and Cyclophilin A. Necrosis appears to be a better therapeutic response as it could further activate pro-inflammatory cytokines to attract immune cells to eliminate HPV-integrated cells and therefore TALEN editing strategy has the potential to be a promising tool as an adjuvant therapy in cervical cancer along with surgery.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of pancreas", "title": "In this study the expression of CypA and its receptor CD147 on pancreatic cancer was determined as well as the effect of exogenous CypA on pancreatic cancer cell proliferation.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of pancreas", "title": "Thus, soluble CypA may affect cell growth of pancreatic cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Early gastric cancer", "title": "Cyclophilin A Enhances Cell Proliferation and Xenografted Tumor Growth of Early Gastric Cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of prostate", "title": "Here, we have shown that induction of CypA is associated with hypoxia in a variety of cells, including DU145 human prostate cancer cell line.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Endometrial Carcinoma", "title": "These data suggest that cyclophilin A may serve as a novel prognostic factor and possibly an attractive therapeutic target for endometrial carcinoma.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Endometrial Carcinoma", "title": "Down-regulation of focal adhesion signaling in response to cyclophilin A knockdown in human endometrial cancer cells, implicated by cDNA microarray analysis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Neurodegenerative Disorders", "title": "Our data point toward distinct CypA structural determinants governing the inhibitor selectivity and the differential biological effects of AIF and CsA, and provide new structural insights for designing CypA/AIF selective inhibitors with therapeutic relevance in neurodegenerative diseases.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carcinogenesis", "title": "Role of cyclophilin a during oncogenesis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carcinogenesis", "title": "Cyclophilin A (CypA) is a cytosolic protein involved in multiple biological functions, such as inflammation, tissue remodeling, tumorigenesis, and vascular diseases.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carcinogenesis", "title": "These results suggest that CypA is important in tumorigenesis, especially in tumor apoptosis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carcinogenesis", "title": "The suppression of CypA expression was correlated with decreased NSCLC cell tumorigenesis and metastasis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carcinogenesis", "title": "These results indicate a special function mode for CypA of playing more important roles in the early stage of gastric tumorigenesis and suggest CypA as a new molecular target of diagnosis and treatment for GC patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Prostate carcinoma", "title": "Here, we have shown that induction of CypA is associated with hypoxia in a variety of cells, including DU145 human prostate cancer cell line.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Prostate carcinoma", "title": "Up-regulated expression of mammary tumor 8 kDa protein (MAT-8), complement component C1S (C1S), ferritin heavy chain (FTH1), peptidyl-prolyl cis-trans isomerase A (PPIA), RNA-binding protein regulatory subunit DJ-1 protein (DJ-1) and vacuolar ATP synthase subunit F (ATP6V1F) was determined in prostate carcinoma and confirmed by using quantitative real-time RT-PCR analyses.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Refractory cancer", "title": "We postulate that the over-expression of CYPA in tumors may play a role in clinical resistance to chemotherapy.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Breast Carcinoma", "title": "The prolyl isomerase cyclophilin A (CypA) regulates the Jak2/Stat5 pathway, which is necessary for mammary differentiation and the pathogenesis of breast cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Breast Carcinoma", "title": "Luciferase assay validated that PPIA was a direct target of miR-192-5p. miR-192-5p sensitizes breast cancer cells to DOX by targeting PPIA, suggesting that miR-192-5p might serve as a novel target for reversing DOX resistance and controlling breast tumor growth.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Breast Carcinoma", "title": "Cyclophilin A (CypA) and ribosomal protein L17 (RPL17) were overexpressed in breast cancer-associated brain metastases, whereas tumor protein 63 (TP63) and von Willebrand factor A domain-containing 8 (VWA8) were significantly downregulated in breast cancer brain metastases.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Breast Carcinoma", "title": "We report that the peptidyl-prolyl isomerase (PPI) cyclophilin A (CypA), which is implicated in the regulation of protein conformation, is necessary for the prolactin (PRL)-induced activation of Jak2 and the progression of human breast cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Breast Carcinoma", "title": "Using MDA-MB-231 as a model breast cancer cell line, we provide evidence that PFN1 overexpression is associated with alterations in the expression of proteins that have been functionally linked to cell proliferation (FKPB1A, HDGF, MIF, PRDX1, TXNRD1, LGALS1, STMN1, LASP1, S100A11, S100A6), survival (HSPE1, HSPB1, HSPD1, HSPA5 and PPIA, YWHAZ, CFL1, NME1) and motility (CFL1, CORO1B, PFN2, PLS3, FLNA, FLNB, NME2, ARHGDIB).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carcinoma of lung", "title": "The current study focused on evaluating the potential of CyPA and MIF as prognostic markers in patients with a new diagnosis of lung cancer for rapid translation into clinical practice.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carcinoma of lung", "title": "Here, we studied the expression of CypA and its receptor CD147 in several kinds of lung cancer cells as well as a normal lung cell and found that in H446 cell, a kind of small cell lung cancer cell, the expression are the highest.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carcinoma of lung", "title": "Cyclophilin A (CypA) is associated with metastasis in diverse cancers; however, its role in lung cancer metastasis and the underlying mechanisms remain poorly understood.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Secondary malignant neoplasm of lymph node", "title": "In this study, we showed that both HIF-1\u03b1 and CypA expression were significantly associated with lymph node metastasis and tumor stage.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Stomach Carcinoma", "title": "Transient suppression of CypA reduced the proliferation of BGC-823 and SGC-7901 GC cell lines.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Acute Chest Syndrome", "title": "We screened participants of the ACS for the C1604G and A1650G polymorphisms in the regulatory regions of CypA.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Acute Cerebrovascular Accidents", "title": "Plasma concentration of Cyclophilin A was measured on admission in 66 consecutive patients who had been hospitalized for acute cerebral stroke and in 52 case-control subjects without a history of acute stroke.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Pregnancy associated hypertension", "title": "Serum CyPA and body mass index were independently associated with the development of complicated pregnancy as pre-eclampsia, GH or GDM.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Cardiomyopathies", "title": "Thus, we first evaluated CyPA expression levels in the right ventricle (RV) tissue specimens obtained from ACM patients and healthy controls (HC) by immunohistochemistry.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "ovarian neoplasm", "title": "Further, CYPA was significantly associated with clinical stage and lymphnode metastasis of SOC patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Ischemic stroke", "title": "Increased plasma Cyclophilin A levels might be involved in the pathophysiology of acute ischemic stroke and Cyclophilin A might serve as a biomarker in risk assessment of acute stroke patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Malignant neoplasm of ovary", "title": "Further, CYPA was significantly associated with clinical stage and lymphnode metastasis of SOC patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Severe Acute Respiratory Syndrome", "title": "Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Attention deficit hyperactivity disorder", "title": "Specifically, the globalEVT method is able to detect genes related to Cyclophilin A like domain proteins which is known to play an important role in the mechanisms of ADHD development.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Inflammatory disorder", "title": "Although the interaction between cyclophilin A and CD147 is well established in inflammatory disease, that of cyclophilin B (CypB) with CD147 has not been fully explored, especially in cancer cell biology, and the exact molecular mechanism underlying such an association is poorly understood.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "The expression level of PPIA was significantly associated with levels of basigin and signal transducer and activator of transcription 3, which may be major effectors of PPIA in the progression of the cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "For example, CypA protein displays an unusually high expression in several cancer types and correlates with poor outcome of the patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "Although overexpression of cyclophilin A (CypA) is associated with several types of cancer, its role in pancreatic cancer has not been studied.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "We apply our approach to elucidate the allosteric mechanism in cyclophilin A (CypA), a peptidyl-prolyl cis-trans isomerase known to participate in diverse biological processes and be associated with many diseases including cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "In this study, A549 and H1299 cell lines with downregulated and overexpressed CypA, respectively, were constructed by lentivirus transfection of NSCLC cells. in vitro experiments, including wound healing and transwell assays and Western blotting, showed that CypA promoted cancer cell migration and epithelial-mesenchymal transition in NSCLC.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "Although the interaction between cyclophilin A and CD147 is well established in inflammatory disease, that of cyclophilin B (CypB) with CD147 has not been fully explored, especially in cancer cell biology, and the exact molecular mechanism underlying such an association is poorly understood.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "Due to its promotive effects on GICs, CypA is a potential target for future glioma therapy.\u003ci\u003e\u003c/i\u003e.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "In response to tumor hypoxia, cyclophilin A (CypA) is over-expressed in various cancer types, and is associated with cell apoptosis, tumor invasion, metastasis, and chemoresistance in PDAC.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "These results demonstrate an important role for CypA in the regulation of Jak2/Stat5-mediated biology in mammary epithelium, identifying this isomerase as a novel target for therapeutic intervention.\u003cb\u003eSignificance:\u003c/b\u003e These findings reveal cyclophilin A functions in normal mammary epithelial development and ErbB2-driven mammary tumorigenesis and suggest therapies targeting cyclophilin A may be efficacious for breast cancer treatment.\u003cb\u003eGraphical Abstract:\u003c/b\u003e http://cancerres.aacrjournals.org/content/canres/78/14/3877/F1.large.jpg \u003ci\u003e\u003c/i\u003e.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Primary malignant neoplasm", "title": "CYPA has been implicated in several pathological processes, including cancer, inflammatory diseases, and HIV-1 infection.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Adult Lymphoma", "title": "Loss of expression of B2M, and gain of expression of PRDX1 and PPIA was confirmed in the cell lines and primary lymphoma tissue.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Childhood Lymphoma", "title": "Loss of expression of B2M, and gain of expression of PRDX1 and PPIA was confirmed in the cell lines and primary lymphoma tissue.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Mammary Neoplasms", "title": "Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Smoking Behaviors", "title": "Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "ST segment elevation myocardial infarction", "title": "Inflammatory biomarkers - pentraxin-3 (PTX3), cyclophilin A (CypA) and heparin-binding epidermal growth factor-like growth factor (HB-EGF) were examined in patients with ST-segment elevation myocardial infarction (STEMI) undergoing revascularization with primary percutaneous coronary intervention (pPCI) and stent implanting.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Latent Tuberculosis", "title": "Earlier, in our immunoproteomic analysis, we found that peptidyl-prolyl cis-trans isomerase A (PpiA) protein-containing fractions induced significantly higher interferon-gamma (IFN-\u03b3) response in LTBI than in PTB.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Glioblastoma Multiforme", "title": "After systemic administration of these new siRNA delivery NPs, they can target the glioma cells and efficiently inhibit the GBM tumor growth by silencing the expression of cyclophilin A (CypA), which is up-regulated in brain cancer and plays an important role in malignant transformation of brain cancer and maintaining glioma cell stemness.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Glioblastoma Multiforme", "title": "These results not only establish the relevance of CypA to glioblastoma growth in vitro and in vivo, but also suggest that small interfering RNA-based CypA knockdown could be an effective therapeutic approach against glioblastomas.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Hereditary Diffuse Gastric Cancer", "title": "Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "ANOPHTHALMIA AND PULMONARY HYPOPLASIA", "title": "Consistent with other studies, HIF-1\u03b1 and CypA promoted PDAC cell proliferation and invasion, and suppressed apoptosis in vitro.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary Artery Disease", "title": "The results indicate that plasma CyPA levels can be used to predict all-cause death, rehospitalization, and coronary revascularization in patients with coronary artery disease and that when combined with other biomarkers (hsCRP and brain natriuretic peptide levels), the CyPA levels have further enhanced prognostic impacts in those patients.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary Artery Disease", "title": "Using an \u003ci\u003eex vivo\u003c/i\u003e model of cultured macrophages isolated from patients with type 2 diabetes with and without coronary artery disease (CAD), we measured the effect of metformin on cyclophilin A expression, lipid accumulation, expression of scavenger receptors, plasma cytokine levels and AMP-activated protein kinase (AMPK) activity in macrophages.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary Artery Disease", "title": "Welchs two-sample t test indicated an association of SNP rs6850: A\u00a0\u003e\u00a0G, located at the 5\u0027 UTR region with increased plasma levels of cyclophilin A in patients with coronary artery disease and with coronary artery disease associated with diabetes.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary Artery Disease", "title": "Moreover, plasma CyPA levels can predict all-cause death in patients with coronary artery disease and pulmonary hypertension.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary Artery Disease", "title": "Genotyping for CyPA PPIA rs6850 was performed in 752 patients with symptomatic CAD.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Coronary Artery Disease", "title": "Interestingly, in patients with acute myocardial infarction (AMI) platelet-bound CyPA was significantly decreased compared with patients with stable CAD.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Low grade glioma", "title": "High expression levels of PPIA were associated with decreased overall survival in low grade glioma, acute myeloid leukemia, lung adenocarcinoma, skin cutaneous melanoma and liver hepatocellular carcinoma (LIHC).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Liver carcinoma", "title": "Mechanistically, cyclophilin A (CypA) was identified as an important molecule for USP4-mediated oncogenic activity in HCC.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Liver carcinoma", "title": "Positivity for CypA was significantly higher in stage III and IV HCC than in stage I and II (p\u003c0.05).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Liver carcinoma", "title": "Our results indicate that PPIA levels were significantly higher in the HCC tissues compared to the matched peritumoral tissues.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Liver carcinoma", "title": "High expression level of peptidylprolyl isomerase A is correlated with poor prognosis of liver hepatocellular carcinoma.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Liver carcinoma", "title": "Finally, overexpression of CypA was observed in human HCC tissues.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Liver carcinoma", "title": "Taken together, our data suggest that CypA promotes HCC cell metastasis at least partially through up-regulation of MMP3 and MMP9.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Liver carcinoma", "title": "Up-regulation of CYPA has been found to be a common phenomenon in several tumor types, including in hepatocellular carcinoma (HCC).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Chronic thromboembolic pulmonary hypertension", "title": "Cyclophilin A as a biomarker for the therapeutic effect of balloon angioplasty in chronic thromboembolic pulmonary hypertension.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Acute pulmonary embolism", "title": "We conclude that the cyclophilin A-CD147 interaction may represent a potential therapeutic target for managing APE.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Nasopharyngeal carcinoma", "title": "In our previous study, five different secretory proteins, including GSN, ADAMTSL4, CALR, PPIA and TXN, have been identified to be associated with the nasopharyngeal carcinoma (NPC) metastasis.In this work, the 5 proteins were further investigated.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Nasopharyngeal carcinoma", "title": "Whether CYPA can be detected in sera of nasopharyngeal carcinoma (NPC) patients remains to be explored.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Peri-Implantitis", "title": "The aim of this split-mouth animal study was to describe variable trends of biomarkers during the progression of peri-implantitis and to define relationships among CyPA, Emmprin, and peri-implantitis.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Secondary Neoplasm", "title": "Additionally, data indicated that knockdown of CYPA by its shRNA dramatically reduces migration and invasion capacity of SOC cells in vitro and blocks tumor metastasis in vivo.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Pulmonary arterial hypertension", "title": "Cyclophilin A (CyPA) can be secreted from cells in response to hypoxia and oxidative stress, which are involved in inducing autophagy and regulating the function of endothelial cells in pulmonary arterial hypertension.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Idiopathic pulmonary arterial hypertension", "title": "Cyclophilin A (CyPA) can be secreted from cells in response to hypoxia and oxidative stress, which are involved in inducing autophagy and regulating the function of endothelial cells in pulmonary arterial hypertension.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Idiopathic pulmonary arterial hypertension", "title": "In transgenic mice that express high levels of CypA in EC specifically, a PAH phenotype was observed at 3 months including increased right ventricular systolic pressure, \u03b1-smooth muscle actin expression in small arterioles, and CD45-positive cells in the lungs.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Middle East Respiratory Syndrome", "title": "Here, we investigated the CypA dependence of three distantly related nidoviruses that can all replicate in Huh7 cells: the arterivirus equine arteritis virus (EAV), the alphacoronavirus human coronavirus 229E (HCoV-229E), and the betacoronavirus Middle East respiratory syndrome coronavirus (MERS-CoV).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Infection", "title": "Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Infection", "title": "Polymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infection.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Skin Erosion", "title": "In vivo experiments found that the cartilage erosion scores in CypA injection group were significantly higher than those in control group (P \u003c 0.05).", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "cervical cancer", "title": "Annexin profiling suggested that cell death could be due to necrosis as observed by upregulation of necrotic markers such as LDH A, Rip-1, and Cyclophilin A. Necrosis appears to be a better therapeutic response as it could further activate pro-inflammatory cytokines to attract immune cells to eliminate HPV-integrated cells and therefore TALEN editing strategy has the potential to be a promising tool as an adjuvant therapy in cervical cancer along with surgery.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "FRONTOMETAPHYSEAL DYSPLASIA 1", "title": "To understand better the role of nonstructural protein 2B of the causative agent FMD virus (FMDV) in the process of virus replication, we identified a porcine host protein, cyclophilin A (CypA), which interacts with FMDV 2B.", "to": "CYPA"}, {"arrows": {"to": {"scaleFactor": 0.5}}, "from": "Carcinoma, Ovarian Epithelial", "title": "Further, CYPA was significantly associated with clinical stage and lymphnode metastasis of SOC patients.", "to": "CYPA"}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {"physics": {"barnesHut": {"gravitationalConstant": -16150, "centralGravity": 0, "springLength": 155}, "minVelocity": 0.75}};

                  


                  

                  network = new vis.Network(container, data, options);

                  

                  

                  


                  
                      network.on("stabilizationProgress", function(params) {
                          document.getElementById('loadingBar').removeAttribute("style");
                          var maxWidth = 496;
                          var minWidth = 20;
                          var widthFactor = params.iterations/params.total;
                          var width = Math.max(minWidth,maxWidth * widthFactor);
                          document.getElementById('bar').style.width = width + 'px';
                          document.getElementById('text').innerHTML = Math.round(widthFactor*100) + '%';
                      });
                      network.once("stabilizationIterationsDone", function() {
                          document.getElementById('text').innerHTML = '100%';
                          document.getElementById('bar').style.width = '496px';
                          document.getElementById('loadingBar').style.opacity = 0;
                          // really clean the dom element
                          setTimeout(function () {document.getElementById('loadingBar').style.display = 'none';}, 500);
                      });
                  

                  return network;

              }
              drawGraph();
        </script>
    </body>
</html>